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ABSTRACT 
 
 
Bionanomaterials have been used in drug delivery, cancer therapy and 
biodiagnosis of pathogens based on their size and surface functionalization. In this 
present work, different kinds of nanoparticles (NPs), their cellular interactions, 
cytotoxicity profiles, and finally role of gold nanoparticles (GNPs) in biodetection of E. 
coli was investigated. 
Firstly, cytotoxicity profiles of commercial, laser ablation, and green synthetic 
NPs were studied. Induction of apoptosis in cancer cells was found to be size dependent.  
The plain 80 nm GNPs and AgNPs enhanced toxic effects in cancer cells when compared 
to 20 nm ones. Apoptotic profiles of ALB- or FBS-coated NPs were significantly low in 
cancer cells when compared to plain NPs. The FBS-coated NPs were relatively bigger. 
Whereas, green synthetic NPs prepared from floral extracts of Tacoma stans and Tagetus 
erecta caused significant increase in cell membrane damage in cancer cells when 
compared to commercial GNPs. The phytochemicals in the extract were found to have a 
synergistic effect on pathogens like E. coli, Staphylococcus aureus and Enterococcus 
faecalis when used with antibiotics like tetracycline, ampicillin and vancomycin. This 
effect can be capitalized in developing NPs as effective drug carriers.  
Next, use of commercial GNPs as diagnostic tools to detect competitive binding 
in DU-145 in the presence of UTI-causing E. coli ORN178 was studied. GNPs 
functionalized with D-mannose (Mn) showed competitive binding between Mn-GNPs 
and E. coli ORN178 when presented together with DU-145 cells. Cytotoxicity assays of 
plain and Mn-GNPs showed significant decrease in viability of DU-145 cells. The 
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plain/Mn 20 nm GNPs were taken up more by the cell when compared to the 200 nm 
ones. The protein-coated GNPs were found to be stable in culture medium. This 
competitive binding can be further developed to prevent/detect recurrent UTI in DU-45 
cells.  
Lastly, primary and fine sugar specificity of fimbrial lectins of E.coli ORN178 
and E. coli 13762 to D-mannose and Neuαc(α2-3)-Gal-(β1-4)Glc–Paa functionalized 
GNPs showed  that E. coli ORN178 binds specifically only to Mn-GNPs and E. coli 
13762 to the latter. Hence, adhesin-specific adhesion shows great potential for designing 
NPs to specifically bind to microorganisms as biodiagnostic tools.  
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CHAPTER ONE 
 
LITERATURE REVIEW 
 
 
 
Nanotechnology 
 
 
Nanotechnology is a field that is undergoing explosive development on various 
fronts. It has found its applications in drinking water purification systems, biological and 
biomedical research areas. The term ‘nano’ indicates one billionth or 10
-9
 units (Sergeev 
2003; Sergeev and Shabatina 2008). Such nanomaterials act as bridge between 
technology and innovative scientific advances. Bionanotechnology is another 
interdisciplinary science that sheds a whole new light of knowledge in understanding the 
intrinsic cellular mechanisms that has opened the window to plethora of treatment 
approaches in biomedical and biological applications of nanomaterials.   
 
Synthesis 
Once the nanoparticles are synthesized by the desired method of synthesis, they 
need to be water solubilized, biofuncationalized before use in various biomedical 
applications. Gold, cobalt, nickel, iron oxide, silica, silver and cadmimum have been 
reported to be synthesized in aqueous solutions. These particles need to be water-
dispersible, the main criteria for their use in biological systems. Size – selective 
precipitation often is tedious multi-step procedure that is not the most desired procedure 
for nanoparticle synthesis. The coprecipitation process is often used for iron oxides 
(Stöber, Fink et al. 1968; Rogach 2000; Wang, Sato et al. 2003; Podsiadlo, Paternel et al. 
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2005; Bao, Wang et al. 2006; Sweeney, Woehrle et al. 2006; Gnanaprakash, Mahadevan 
et al. 2007; Lu, Tung et al. 2008). Gold and silver nanoparticles are prepared by the 
reduction method with the use of reducing agents (Daniel and Astruc 2003; 
Gnanaprakash, Philip et al. 2007). Non-polar solvents also have been used to synthesize 
nanoparticles with the help of organic solvents that help grow the crystal structure and 
regulate the size of the nanoparticles (Brust, Walker et al. 1994; Sun, Murray et al. 2000; 
Gittins and Caruso 2001; Gnanaprakash, Mahadevan et al. 2007; Lu, Tung et al. 2008). 
Spherical nanoparticles are generally produced via the simple reduction of metal salts by 
the use of reducing agents. Since spherical nanoparticles exist in low-energy state, they 
have been frequently prepared by the Turkevich method, Frens method, microemulsion 
method, and the Brust method (Murphy, Sau et al. 2005).  
Lately laser ablation synthesis in liquid solution has gained increased attention. 
Laser ablation process involves synthesis of nanoparticles in a one-step process. Such 
particles have extremely high colloidal stability due to their inherent surface charge, 
resulting in stable free NPs. The surface chemistry of laser-ablated metal nanoparticles is 
reported to have negative charge which makes it electrostatically stable (Muto, Miyajima 
et al. 2008). NPs prepared by this method allow for control of nanoparticle size 
distribution and produce mono-disperse particles (Men nde -Man  n, Chich o  et al. 
2010). In this method nanomaterials are produced by focusing laser pulses on a target 
(single piece or pressed powder) immersed in a liquid solution. The material and laser 
parameters result in nanoparticles that are stable colloids (Amendola and Meneghetti 
2007; Bueno-Alejo, D'Alfonso et al. 2012). It is a sustainable technology in which 
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various aqueous media can be used (Murphy 2008). Apart from being a low-cost method, 
it is one of the fastest and cheapest ways to produce colloidal nanoparticles (Amendola, 
Meneghetti et al. 2011). This process allows for significant control of particle size, 
concentration, and aggregation. These parameters allow for easy functionalization by 
various ligands (Amendola, Polizzi et al. 2006).  
Synthesis and characterization of silver and gold nanomaterials can be done by 
chemical and physical methods as discussed above.  
The biological method of synthesis of nanoparticles is also called as the ‘green 
approach’. Polymers, surfactants, co-polymers, dendrimers, starch, and lipids are 
necessary to achieve fine and stable catalysis of nanoparticles in the chemical and 
physical methods. Some of the compounds that are used as stabilizing and/or capping 
agents in chemical synthesis of nanoparticles could be toxic. Whereas the green approach 
is economical, environment friendly, and can be easily adapted for large scale production 
(Buffat and Borel 1976; Jain, Varshney et al. 1989; Esumi, Hosoya et al. 2000; Chen, 
Herricks et al. 2005; Bakshi, Possmayer et al. 2008; Agasti, Chompoosor et al. 2009; 
Gupta, Singh et al. 2010). It also does not involve high energy, pressure, temperature, and 
toxic chemicals. Plenty of research has been published where in extracts from algae, 
bacteria, fungi, leafs, plants, and yeast have been used to synthesize silver and gold 
nanoparticles. It is quite interesting to note here that these extracts themselves have been 
shown to act as reducing, capping, and sometimes shape directing agents (Freund and 
Spiro 1985; Mehra and Winge 1991; Wang and Herron 1991; Grunwaldt, Kiener et al. 
1999; Gardea-Torresdey, Parsons et al. 2002; Sanghi and Verma 2009). Extracts of neem 
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leaves, geranium, lemongrass, tamarind, and aloe vera plant have been used to synthesize 
various shaped mono- and bi-metallic gold and silver core shell nanoparticles (Shankar, 
Ahmad et al. 2003; Shankar, Rai et al. 2004; Shankar, Rai et al. 2004; Ankamwar, Damle 
et al. 2005; Shankar, Rai et al. 2005; Chandran, Chaudhary et al. 2006). The extracts of 
fruit, fruit peel, root, callus, and bark also have been used to synthesis nanoparticles 
(Ahmad, Sharma et al. 2010; MubarakAli, Thajuddin et al. 2011; Prathna, 
Chandrasekaran et al. 2011; Rai, Yadav et al. 2012). Vegetable extracts have also been 
used for the facile synthesis of silver, anisotropic gold, and bimetallic nanoparticles using 
cruciferous vegetable extracts (Jacob, Mukherjee et al. 2012).  
Researchers have also used other leaf extracts of Crossandra, infundibuliformis, 
Acalypaindica, Rizophora mucronata, Menthapiperita, Azadirachta indica, Stevia 
rebaudiana, Chenopodium album, Cassia fistula, and even banana peel extract (Shankar, 
Rai et al. 2004; Rai, Yadav et al. 2009; Gnanadesigan, Anand et al. 2011; MubarakAli, 
Thajuddin et al. 2011; Yilmaz, Turkdemir et al. 2011). Silver nanoparticles synthesized 
in this manner shown enhanced fluorescence and surface-enhanced Raman scattering thus 
making it most useful in optical applications (Dastjerdi, Montazer et al. 2009; Li, Xie et 
al. 2010). Raju et al. used Annonna squamosa leaf extract to extract dominant stable 
spherical silver nanoparticles with an average size ranging from 20-100 nm (Vivek, 
Thangam et al. 2012). Green tea leaves extract has been used to synthesize plant 
mediated catalysis of 20 nm gold nanoparticles (Zaki, El Kady et al. 2011). Fifteen nm 
silver nanoparticles synthesized using dried medicinal plant of basil have also been 
reported (Ahmad, Sharma et al. 2010). Green production of zero-valent iron 
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nanoparticles using 26 different tree leaf extracts have been reported by Machado et al. 
(Machado, Pinto et al. 2013). Biosynthesis of NPs from plants, such as Chenopodium 
album, Sorbus aucuparia, sugar beet pulp, Terminalia catappa, Hisbiscus rosa sinensis, 
Mangifera indica, Syzygium aromaticum, Anacardium occidentale and Murraya koenigii 
have been recently demonstrated (Ankamwar 2010; Dwivedi and Gopal 2010; Philip 
2010; Philip 2010; Philip, Unni et al. 2011; Sheny, Mathew et al. 2011).  
The synthesis methods using plant extracts involve phytochemicals like 
terpenoids, flavonoids, phenol derivatives, di-hydric phenols, plant enzymes and hence 
act as reductants in the presence of metal salts. It is established that based on the type of 
extract, structure and type of phenolic phytochemicals present in the extract, different 
shaped and sized nanoparticles are formed (Jha, Prasad et al. 2009; Kumar, Yadav et al. 
2010; Raghunandan, Bedre et al. 2010; Thakkar, Mhatre et al. 2010; Jacob, Biswas et al. 
2011; Jagajjanani Rao and Paria 2013). Interestingly, microorganisms also have been 
used for the biological synthesis of nanoparticles such as Pseudomonas stutzeri AG259, 
fungi, actinomycetes, cyanobacteria, and biomolecules (Gopinath, MubarakAli et al. 
2012). 
Green catalysis aspects obviously require that environmentally friendly catalysts 
be designed for easy removal from the reaction media and recycling many time with very 
high efficiency. But most importantly, application of eco-friendly nanoparticles makes 
this method preferable for large scale synthesis (Khan, Bashir et al. 2012). Almost all 
studies report a general trend of antimicrobial properties more enhanced in green 
synthesis particles than nanoparticles synthesized by chemical or physical methods.  
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Ligands 
Having briefly discussed the methods of synthesis, the stabilization of the 
nanoparticles is the next step where one needs to make sure that the nanoparticle colloidal 
suspensions are physically and chemically stable, do not aggregate, dissociate or do not 
lose their metallic properties as they age. For this purpose, they are stabilized with 
hydrophilic ligands. There are different kinds of ligands that can be used. Ionic 
stabilization has been studied extensively and it has been reported that even though they 
are charged well, their high charge can sometimes be disadvantageous as they can be 
readily opsonized by cells easily (Berry 2009). Since it has been established that 
positively charged nanoparticles have longer circulation in the blood compared to 
negatively charged nanoparticles, the coulumbic repulsion based on the charge of the 
nanoparticle plays an important role in medical applications (Rideal 1951; Mandeville, 
Marota et al. 1998; Daou, Begin-Colin et al. 2007; Longmire, Choyke et al. 2008). 
Ligands are often used to maintain the stability of the particle, which in turn maintains 
the size distribution post-synthesis. These ligands are usually surfactants such as fatty 
acids, thiols or alkene thiols, which usually render the particle hydrophobic and hence, 
they need to be further stabilized with amphiphilic ligands such as protein, peptides and 
thermoresponsive polymers (N.T.K. Thanh 2004; Robinson, Alexander et al. 2007).  
Steric stabilization using polymeric ligands and small-molecule ligands like 
ethylene glycol, which is commonly used, can be used to stabilize the nanoparticle to 
provide enhanced chemical functionality or ionic stabilization (Hong, Han et al. 2006; 
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Chompoosor, Han et al. 2008; Nativo, Prior et al. 2008). The ethylene glycol end can be 
further modified to attach another amphiphilic molecule for further functionalization 
(Berry, Wells et al. 2003; Park, Im et al. 2005; Chairam and Somsook 2008). Oxygen 
based ligands like polyols, polyehters, carbohydrates, alcohols, carbonyls are neutral 
ligands that have been used to control the size selective precipitation of the nanoparticles 
(Chen, Liu et al. 2002; Daniel and Astruc 2003; Xu, Xu et al. 2004). However, the 
stability varies for different nanoparticles. Nitrogen- based ligands are also used but these 
ionically stabilized nanoparticles salt out in the presence of electrolyte concentrations 
well below physiological conditions (Brust, Walker et al. 1994; Gittins and Caruso 2001; 
Charbonniere, Rehspringer et al. 2008). Even though phosphorous and sulfur-based 
ligands have been used to functionalize nanoparticles, it has been reported that the 
stability is the main concern of the entire process (Ulman 1996; Letsinger, Elghanian et 
al. 2000; Yonezawa, Yasui et al. 2000; Sahoo, Pizem et al. 2001; White, Johnson et al. 
2006; Joumaa, Toussay et al. 2008; Polito, Colombo et al. 2008). This is determined by 
the ligand-surface bond, the packing of the ligand chain, length of the ligand tail, and 
stacking of the ligand (Porter, Bright et al. 1987; Tadmor, Rosensweig et al. 2000; Parak, 
Pellegrino et al. 2002; Agasti, You et al. 2008). Light induced reactions often lead to the 
desorption of the ligands (Stouwdam, Shan et al. 2006).  
 
Effect of ligands 
Since the ligands are essential for the nanoparticle surface characterization, it 
must be noted that they will, most of the time, determine how a nanoparticle will behave 
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in in vitro or in vivo conditions. It has been reported that uncoated nanoparticles are 
cytotoxic (Gupta, Berry et al. 2003; Berry 2009; Nune, Gunda et al. 2009). There is no 
defined map that can be laid out and direct the nanoparticle to cause the desired effects in 
a planned fashion. This aspect of nanoscience in fact has attracted a large number of 
research groups to study the cytotoxicity of the nanoparticles in order to decipher their 
behavior in the biological system and make them safer for various applications 
(Maenosono, Yoshida et al. ; Lewinski, Colvin et al. 2008; Verma and Stellacci 2010; 
Zolnik, González-Fernández et al. 2010). Since this review mainly pivots around the 
biological applications of the nanoparticles, it is important to know the different 
biofunctionalization moieties that are being used.  
 
Surface functionalization 
The optical and electronic properties of Au-NPs offer an enormous potential in 
nanoscience and engineering applications (Bawendi, Steigerwald et al. 1990; Wang and 
Herron 1996; Collier, Vossmeyer et al. 1998). Therefore, surface functionalization of 
metallic nanoparticles will greatly expand the range of applications of these materials. 
Two basic approaches can be taken toward the creation of functionalized gold 
nanoparticles. One is performing the surface modification of already available colloidal 
gold preparations by chemisorbing thiols, and the other implies the synthesis of colloidal 
metals with an organic monolayer in a one-step procedure. The latter is most commonly 
based on modifications to the synthetic procedure originally reported by Brust to create 
metallic nanoparticles (Brust, Walker et al. 1994; Brust, Fink et al. 1995). Brust’s 
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synthesis consists of reducing a metallic salt (e.g., AuCl4H) in the presence of an 
alkanethiol and results in nanoparticles protected by an organic monolayer which are 
called monolayer-protected clusters (MPCs). Such a monolayer confers these systems 
with new surface properties and also with extraordinary stability such that they can be 
isolated and manipulated with a variety of chemical and physical procedures to the extent 
that they can be dried and resuspended in solution again without suffering irreversible 
aggregation or decomposition (Chen and Kimura 1999; Yee, Scotti et al. 1999; Aguila 
and Murray 2000; Cliffel, Zamborini et al. 2000; Templeton, Wuelfing et al. 2000; 
Templeton, Pietron et al. 2000; Kometani, Tsubonishi et al. 2001; Shon, Mazzitelli et al. 
2001). 
In general, the synthesis of MPCs yields polydisperse size distributions of 
nanoparticles of sizes under 10 nm. (Bawendi, Steigerwald et al. 1990; Chen and Kimura 
1999; Yee, Scotti et al. 1999; Kometani, Tsubonishi et al. 2001). For some applications, 
it may be desirable to obtain functionalized gold nanoparticles of sizes larger than these 
MPCs and with monodisperse sizes. For example, quantum dot (QD) superlattices can be 
better assembled from single-sized nanoparticles or from colloids with narrow size 
distributions (Bawendi, Steigerwald et al. 1990). This and the fact that larger colloids 
may offer a broader range of properties and applications have motivated us to study the 
stability of commercial preparations of colloidal gold upon surface modification by 
chemisorption of alkanethiols. Colloidal gold is commercially available in monodisperse 
sizes on the order of tens of nanometers, whereas MPCs have typical polydisperse size 
distributions on the order of 1-10 nm. Also, the synthesis and characterization of MPCs 
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may become expensive and time consuming. However, colloidal gold can undergo 
irreversible aggregation upon chemisorption of alkanethiols (Weisbecker, Merritt et al. 
1996; Mayya, Patil et al. 1997; Templeton, Wuelfing et al. 2000).  
This kind of functionalization further helps in providing technical advantages for 
applying gold nanoparticles in biological systems, which have been well recognized 
(Kreuter 1996). The covalent binding between gold nanoparticles and biomolecules can 
be easily achieved by self-assembled thiolated molecules onto the nanoparticle surface 
(Mathai Mammen 1998). Multiple carbohydrate ligands have been assembled on linear 
polymers (Gestwicki and Kiessling 2002),  two-dimensional gold surface (Mann, Kanai 
et al. 1998; Liang, Smith et al. 2000; Lin, Yeh et al. 2002) and liposomes (Kingery-
Wood, Williams et al. 1992) to enhance carbohydrate-protein interactions. 
 
Biofunctionalization 
Coupling reactions commonly include carbodimiimide, ionic and maleimide 
coupling, click chemistry, disulfide bridges and histidine tagged proteins (Thanh and 
Green 2010). Various compounds have been used to functionalize nanoparticles in order 
to make their surface interactions compatible with the cellular environment. Chitosan also 
has been found to be biocompatible and used in various applications (Lewin, Carlesso et 
al. 2000; Wang, Zhang et al. 2006; Chairam, Poolperm et al. 2009). Bacterial and 
mammalian cell surfaces are rich in phospholipids. This has been exploited by 
bioconjugating nanoparticles with phospholipids. Biotin-avidin interactions have been 
investigated for drug delivery and hyperthermic applications (Giri, Guha Thakurta et al. 
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2005; Senarath-Yapa, Phimphivong et al. 2007). Signal transduction at cellular level has 
been attempted by functionalization of nanoparticles with peptide sequences (Lewin, 
Carlesso et al. 2000; Torchilin 2008). Proteins are vital biomolecules that determine the 
fate of the nanoparticle in vivo. They not only determine the specific binding interactions 
of nanoparticles but also determine the toxic effects when inside the cell. Biodetection of 
antigens with the help of antibody tagged nanoparticles has shown specific and non-
specific interactions (Dyal, Loos et al. 2003; Gupta, Berry et al. 2003; Lin, Chou et al. 
2006; Bonasio, Carman et al. 2007). Protein corona of nanoparticles has shown that 
nanoparticles are less cytotoxic and enhance cellular uptake (Konerac á, Kopčans ý et 
al. 1999; Huh, Jun et al. 2005). 
Carbohydrates have been extensively used in microbial detection (Berry, Wells et 
al. 2003; Chairam and Somsook 2008; Chompoosor, Han et al. 2008). Carbohydrates on 
the host surface play an important role for the pathogen binding and colonization. The 
carbohydrate-protein interaction primarily decides adhesion of the pathogen leading to 
internalization (Sharon and Lis 1989; Karlsson, Angström et al. 1992).  Facilitating anti-
adhesion to fight microbial antibiotic resistance is one such approach in nanotechnology 
(Balland, Pinto-Alphandary et al. 1996; Sondi and Salopek-Sondi 2004; Naruse 2005; 
Shi, Neoh et al. 2006). Initial phase of pathogenesis involves attachment of bacterial to 
the mucosal surfaces. Bacterial surfaces consist of adhesins that are characteristic for 
each bacterial and often determine the attachment to host cell membrane receptors. There 
are fimbrial adhesins often located on the fimbriae of the bacteria. The fimbrial adhesins 
can result in specific binding interactions with the host cell surface. There are different 
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kinds of fimbrial adhesion mechanisms of which are type 1 (mannosylated) and P-
fimbriated adhesion (galabiose). The primary sugar specificity of bacteria dictates its 
fimbrial adhesion mechanism to the host cells (Wentworth, Austin et al. 1991; Mitchell, 
Houles et al. 2002; Loris, Tielker et al. 2003). Basing on this principle, engineered 
nanoparticles that are functionalized with carbohydrates have been used in drug delivery, 
biodiagnosis, biodetection and other biomedical applications (Varshney, Yang et al. 
2005). 
 
Characterization 
Once synthesized, the nanoparticles need to be characterized in order to 
understand their surface chemistry for further applications and controlled nanoparticle 
synthesis. It is important to determine the particles size, shape, crystalline structure, 
fractal dimensions, pore size, surface area, surface plasmon resonance, electrodynamic 
surface chemistry and stability of the synthesized nanoparticles (Priyadarshini, Gopinath 
et al. 2013). Different techniques are available that are being used extensively for the 
above studies such as transmission and scanning electron microscopy (TEM/SEM), UV-
Vis spectroscopy, powder X-ray diffractometry (XRD), atomic force microscopy (AFM), 
X-ray photoelectron spectroscopy (XPS), dynamic light scattering (DLS) and Fourier 
transform infrared spectroscopy (FTIR), thermal gravimetric analysis (TGA) and 
nanoparticle shape and configuration analysis by electron topography analysis 
(Khomutov and Gubin 2002; Yeo, Lee et al. 2003; Chimentao, Kirm et al. 2004; Zhang, 
Tanha et al. 2004; Agasti, You et al. 2008; Vilchis-Nestor, Sánchez-Mendieta et al. 
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2008). These tools have made easy qualitative and quantitative identification of 
nanoparticle behavior in vitro feasible.  
 
Gold nanoparticles  
Gold nanoparticles at nanoscale (~100 nm or less) exhibit brilliant colors. The 
dielectric constant for gold is in the visible region of the electromagnetic spectrum (El-
Sayed 2001). The plasmon frequency of nanoparticles is uniquely sensitive to the 
dielectric interaction in the liquid they are dispersed. Any surface modification or 
aggregation leads to the shift in surface plasmon resulting in a color change (El-Sayed 
2001; Murphy 2002; Kelly, Coronado et al. 2003; Burda, Chen et al. 2005; Rosi and 
Mirkin 2005). This property is mainly used for chemical sensing and imaging 
applications as coupling of plasmons due to shift in plasmon frequency makes it possible 
to optically track the nanoparticles (Daniel and Astruc 2004; Rosi and Mirkin 2005). Not 
only they can synthesized in different shapes and sizes, their optical properties make 
them an excellent candidate in drug encapsulation, gene therapy, biodiagnosis, 
bioimaging and anticancer applications (Dhar, Daniel et al. 2009; Yen, Hsu et al. 2009). 
Therefore, gold nanoparticles that belong to the noble metal family exhibit interesting 
properties making them the most suitable candidate for nanomedicine.  
Silver nanoparticles, in contrast, have been used predominantly as anti-bacterial 
agents in food, health, and textile industries (Gupta and Silver 1998; Bosetti, Massè et al. 
2002; Vivek, Thangam et al. 2012). Owing to their broad spectrum of antimicrobial 
activity and surface plasmon resonance effects, silver nanoparticles (AgNPs) have gained 
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much popularity. They have also been used for several environmental applications (Abou 
El-Nour, Eftaiha et al. 2010). Research has shown that cotton fibers are highly anti-
bacterial against Escherichia coli (Yeo, Lee et al. 2003; Chen and Chiang 2008). Among 
the wide range of applications from simple water purification in home appliances to 
disinfection of biomedical devices, wound dressings, bond prostheses and heart valves 
and biosensing are a few (Dubas and Pimpan 2008; Xu, Yang et al. 2008). Due to their 
electrochemical properties, they have been incorporated in sensors that offer faster and 
lower detection limits. It has been showed that the bleaching of the organic dyes by 
application of silver nanoparticles can be enhanced at room temperatures (Köhler, 
Abahmane et al. 2008). Silver nanoparticles have been used as biological labels because 
of their fluorescent emissions from silver nano clusters (Mulvaney 1996; El-Sayed 2001; 
Kelly, Coronado et al. 2002; Berciaud, Cognet et al. 2005; Kossyrev, Yin et al. 2005; Jia, 
Ma et al. 2008).  
 
Cytotoxicity of Gold nanoparticles 
Use of gold nanoparticles in various applications largely deals with their uptake, 
cellular toxicity, biocompatibility and ultimately their disposal from biological systems. 
This is very important in regard to their clinical applications. There is a subtle difference 
between cytotoxicity, cellular damage and genotoxicity of nanoparticles. Nanoparticles 
can be capable of causing cellular damage but not exhibiting any toxicity. The cells might 
initiate processes to combat the cellular damage but might not effectively replicate. 
Citrate-capped gold nanoparticles of 13 nm were found to be toxic to skin cells but 
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inhibited cell proliferation (Nadine Pernodet 2006). Based on the different types of cell 
lines the cytotoxicity has been reported to vary. Citrate-capped nanospheres of gold are 
not cytotoxic to baby hamster kidney and human liver cells, but cytotoxic to human lung 
cancer cell line(Patra, Banerjee et al. 2007). In general, they have been found to be 
nontoxic in low doses and but toxic as dosage increases. Gold nanoparticles are taken up 
by human leukemia cells (Nikoobakht and El-Sayed 2001; Connor, Mwamuka et al. 
2005; Sau and Murphy 2005). The reduction in the amount of harmful reactive oxygen 
species (ROS) to the immune system cells has been reported (Shukla, Thomas et al. 
2005). Gold nanometers of 50 nm were reported to be taken up quickly by HeLa, a 
human cervical cancer cell line (Chithrani, Ghazani et al. 2006). Studies have also shown 
that gold nanoparticles of 14-100 nm have been taken up by cells but have no cytotoxic 
effects (Chithrani, Jelveh et al. 2010). The surface modifications, net surface charge, size  
and the physical dimensions of the gold nanoparticles have been shown to play an 
important role in the difference in cytotoxic effects (Connor, Mwamuka et al. 2005). 
Whereas due to the widespread use of silver nanoparticles in medicine, the body exposure 
to these nanoparticles is more compared to gold nanoparticles. Decreased mitochondrial 
function, DNA damage, induced cell apoptosis, and necrotic cell death for several types 
of cells have been reported (AshaRani, Low Kah Mun et al. 2009).  
Particle stability plays an important role in uptake and cytotoxic effects. Zeta 
potentials of particles reflect the net surface charge of particles. Charged particles 
(cationic or anionic) display different rates of uptake when compared to particles whose 
zeta potential values are close to zero (Roser, Fischer et al. 1998). Cytotoxicity includes 
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the induction of immunological response in the cells that can lead to proinflammatory 
response which leads to gene expression. Often this leads to onset of endocytosis – one of 
the vital mechanisms by which macrophages expunge foreign material in the cell. 
Phagocytosis, pinocytosis and receptor mediated endocytosis are integral parts of 
endocytic mechanisms of the cell (Kruth, Jones et al. 2005). In general, it has been shown 
that phagocytosis occurs for most nanoparticles that are larger than 100 nm and 
pinocytosis occurs for nanoparticles less than 100 nm. However, protein coated 
nanoparticles with albumin or transferrin can not only enter the cells via a receptor 
mediated endocytic pathway but also escape into cellular organelles (Chithrani and Chan 
2007). The protein corona is a fascinating approach where by uptake of nanoparticles by 
pinocytosis can be avoided and receptor based endocytosis can be achieved. The former 
simply would lead to aggregation in the cell vesicle, whereas the latter is taken up 
actively via a coated vesicle (Chithrani, Ghazani et al. 2006).  
The protein corona not only helps in the uptake of the nanoparticles but also 
brings about less cytotoxicity in the cells. Due to the protein coating around the 
nanoparticles, the negative surface charges interact with the receptor proteins that 
changes the conformation of the cell surface receptors and allows the negatively charged 
proteins to be more readily absorbed on to positively charged substances (albumin, 
fibrinogen, fetal bovine serum, transferrin etc.). Therefore, in other words, protein corona 
shows promising effects that can steer the nanoparticle’s fate in the cell. Howe er it has 
been shown that higher the immunological responses in gold nanoparticles than silver 
nanoparticles could be related to their uptake mechanisms (Podila, Vedantam et al. 
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2012). The surface zeta potentials impact the aggregation of nanoparticles based on their 
hydrophobicity or hydrophilicity. Differences in zeta potentials has been attributed to 
different cytotoxicity profiles of gold and silver nanoparticles (Lundqvist, Stigler et al. 
2011).  
 
Applications of NPs 
Nanomedicine is a science that is fairly developed and requires decades of 
research in order to understand the potential treatment options nanotechnology offers in 
personalized treatment of diseases. The benefits are such as accuracy, speed of treatment, 
efficacy and safety. There has been great amount of short term and long term research 
that has been done in this regard. Commercial nanomedicine is at its early stages of 
development. There has been a great deal of development of nanovectors and site 
targeted nanosystems. Multifunctionality of nanocantilevers, nanowires and nanotubes 
has made it possible to detect molecular signals in real time. These kinds of systems help 
in the detection, diagnosis and prognosis of cancer.  
Early detection systems that detect the early stages of cancer will help in the 
treatment of the disease. This being one of the most critical point, it is important to 
achieve full recovery of the disease. In the current treatment methods, it is possible to 
treat cancer in an effective manner once detected early and not metastasized. Many nano-
based technologies are being studied for prognosis of the tumor stages in cancer. It is 
important to find least invasive methods for the same. Once it is detected, the effective 
tumor targeting technique is crucial for treatment. There has been plenty of research done 
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with nanoparticles that have acted as carriers for releasing drugs in targeted drug delivery 
method. This kind of approach will help opt for treatment options by passing the surgery 
and the chemotherapy route. Since there is overwhelming information in this regard this 
section of the review will pivot mainly around the biomedical technology that is of 
therapeutic value and promising enough to better patient care. 
 
Nanomedical applications 
The future of nanomedicine is steering towards eliminating bacterial infections in 
patients by passing the use of antibiotics, surgery at the cellular level, repairing damaged 
tissues and cells. The biggest hurdle is to engineer nanoparticles that can get around 
biological barriers. The tight junctions between cells, the blood-brain barrier, the 
filtration systems in the body and there are various bio-physical barriers that slow down 
the extravasation of vascularly injected agents (Grossman and McNeil 2012).  
Targeting has been approached by two modalities in cancer nanotechnology, 
active and passive. Directly involves linking of nanoparticles directly to the ligands that 
identify and associate with the tumor specific cells. The antibody conjugated approach is 
one such where the nanoparticles is made to localize with cell surface proteins.  Specific 
targeting of blood vessels has been demonstrated (Akerman, Chan et al. 2002; Wu, Liu et 
al. 2003; Paciotti, Myer et al. 2004; Nida, Rahman et al. 2005). The passive approach 
takes advantage of the nano size of the nanoparticles and the tumor vasculature. Since the 
tumor vasculature is unlike the normal endothelium with wide fenestrations, the large 
pore sizes allow the passage of nanoparticles into the tumor. It is seen that nanoparticles 
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do reach inside the tumor and this brings about the advantage of tailoring a nanoparticle 
linked to various drugs, proteins and polymers to treat the tumor (Hobbs, Monsky et al. 
1998; Schaeffer, Tan et al. 2008; Seigneuric, Markey et al. 2010; Shao, Gao et al. 2011; 
Mukerjee, Ranjan et al. 2012; Lee, Qian et al. 2013; Stefanick, Ashley et al. 2013).  
It has been demonstrated that nanoparticles coated with albumin and bound to 
drug paclitaxel was more efficient in treating metastatic breast cancer pateints (Gradishar, 
Tjulandin et al. 2005). Abraxane was approved by the FDA in 2005 for the treatment of 
metastatic breast cancer, which consists of paclitaxel nanoparticles that are bound to 
albumin molecules. This combination allows it to cross the vascular endothelium barrier 
across blood vessels and hence 50% greater clinical dosages of the drug. In a study 
conducted in rats, poloxamer 188-coated PLGA nanoparticles enable delivery of 
doxorubicin across the blood-brain barrier in the therapeutically effective concentrations 
to treat glioblastoma (Wohlfart, Khalansky et al. 2011). Various nanosystems also have 
been reported to cross the blood brain barrier which include thiamine coated 
nanoparticles (Lockman, Oyewumi et al. 2003), in situ transport of nanoparticles across 
the blood brain barrier and drug delivery (Koziara, Lockman et al. 2003).  
Enzymatic digestion of the drug coated, the delayed release of the drug, 
penetration of the orally administered biomolecular agents thought the intestinal barrier, 
has led to development of synthetic nanoparticles that can be biological, therapeutic and 
clinical agents (Chen, Torchilin et al. 1996; Wu, Akaike et al. 1998; Martin and Grove 
2001; Tao, Lubeley et al. 2003; Lundqvist, Stigler et al. 2011; Li, Nielsen et al. 2012). 
The cells of the reticuloendothelial system act as one of the biological and immunological 
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barriers to targeting of nanoparticle-encapsulated drugs. Surface modifications do aid in 
tackling this impediment and one such polymer is polyethylene glycol (PEG). It has been 
demonstrated that Peg increases the circulatory half-life to hours/days when used in 
tumor targeting (Klibanov, Maruyama et al. 1991; Park 2002; Park, Benz et al. 2004; 
Deng, Ke et al. 2012).  
Another approach has been tagging antibodies to nanovectors to treat various 
tumors. Carbon nanotubes, dendrimers and gold nanoparticles have been used for 
treatment and it has been seen that the particles when bound to protein sensitize the tumor 
tissue and initiate an immunogenic response towards themselves (Lee, Parthasarathy et 
al. 2001; Lee, Parthasarathy et al. 2004; Desai 2012). The tumor tissue itself acts as a 
biophysical barrier sometimes. The increased osmotic pressure in the lesions, the 
metastatic nature of the tumor and presence of dead cells blocking the release of the drug 
are few. The diffusion of the drug loaded agents into the tumor results in imbalance in 
pressure and risk the effusion of the therapeutic agent out of the site of injection 
altogether. There has also been research showing that nanoparticles provide 
spatiotemporal control of drug release and enhanced tissue penetration (Netti, Baxter et 
al. 1995; Sarntinoranont, Rooney et al. 2003; Stylianopoulos, Martin et al. 2012; Tong, 
Hemmati et al. 2012).  
Targeting efficacy is an important aspect in cancer lesions and tumors. The tumor 
microenvironment and tumor angiogenesis present the biggest hurdle to targeted drug 
delivery systems. Most of the chemotherapeutic agents lead to systemic toxicity with 
potential side effects. The leaky vaculature of the tumor tissue helps in enhanced 
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permeability. Hence, the nanocarriers allow active targeting by successfully binding to 
the surface receptors of the cancer cells. Directional targeting of the nanosystems has 
been shown that delivery of cytotoxic agents to the tumor site might lead to the breaking 
down of the lesions into small neoplasms (Sinek, Frieboes et al. 2004; Danhier, Feron et 
al. 2010).  
Controlled release of the drug in the treatment of prostate cancer has been 
demonstrated that resulted in therapeutic advantage, reduction of side effects of 
chemotherapy, regularity of dosing and targeted delivery. Drug delivery systems when 
administered need to be selective and effective. For which it is important to determine the 
right amount of drug, right time and right target in the body. Direct injection of the 
nanosystems loaded with drugs is mostly the preferred choice. The binding affinity of the 
particles to the cells is affected by binding force and growth rate with time. The 
hemodynamics play an important role in the viscoelastic properties of the particle 
targeting the cell (Decuzzi, Lee et al. 2004).  
For example, to enhance the increased uptake of anticancer agents, folic acid has 
been employed as a targeting ligand and found to increase their cellular uptake within 
target cells since the folate receptor is overexpressed on the surface of tumor cells 
(Zwicke, Mansoori et al. 2012). One such study in human breast cancer cells MCF-7 
indicated that the paclitaxel loaded folic acid micelle is a successful anticancer-targeted 
drug-delivery system for effective cancer chemotherapy (Wang, Chen et al. 2012). 
Biodistribution and tumor retention in vivo studies carried out in human nasopharyngeal 
carcinoma tumor-bearing athymic mice , indicate that intracellular targeting of 
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nanoparticles by folate is enhanced (Oyewumi, Yokel et al. 2004). On the other hand 
there has been research showing that development of nanoscale drug delivery could be 
engineered in such a manner that would not only allow intracellular delivery also have an 
imaging capability for tracking the uptake of the material introduced. Growth inhibitory 
oligonucleotides have been linked to dendrimers and introduced to treat breast, ovarian 
and prostate cell lines effectively (Santhakumaran, Thomas et al. 2004). Identification 
systems consisting of oliguncleotide-bound gold and magnetic nanoparticles have been 
developed that carry a predefined sequence, this system hence becomes more sensitive 
than PCR (Nam, Stoeva et al. 2004; Vetrone, Huarng et al. 2012).  
Gold nanoparticles in conjuction with microcantilevers have been developed that 
can detect single mismatch errors in DNA molecule (Su, Li et al. 2003). Hence, there has 
been technology that has been developed to detect specific molecular changes in cancer 
cells, but the sensitivity behind each innovation is mainly that matters the most. Another 
approach of theragnostic nanotechnology involves siRNA therapy of tumor tissue. This 
therapy is nothing but gene therapy that involves use of nucleotide drugs for clinical 
purpose instead of the conventional chemical drugs. This approach has dual advantages 
of treatment as well as tracking/imaging of the treatment. siRNAs bound to RNA-induced 
silencing complex (RISC) with silencing activity is introduced that brings about 
degradation of the target RNA sequence (mRNA). Hence, in cancer cells there is over 
expression of proteins. By employing this technique the siRNA can be introduced in the 
target cell cytosol and suppress specific surface proteins. Many nanosystems like metals, 
lipids and polymers have been used (Lee, Lee et al. 2010; Zarbin, Montemagno et al. 
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2010; da Paz, Santos Mde et al. 2012; Lee, Kim et al. 2012; Balasubramanian, Ravindran 
Girija et al. 2013). This concept is fairly new and is diagnostic in nature and one can 
monitor the therapeutic treatment at the same time. By this it is easy for clinicians to 
administer, monitor and alter the treatment depending on the patient response.  
In summary there are opportunities to for developing entirely new therapeutics 
which can be safer and more effective in the diagnostic areas to fight cancer. The most 
promising area being the drug encapsulated nanoparticles. Various platforms that have 
emerged using nanotechnology have successfully shown treatment efficacy, safety and 
practicality of the approach is the key to target tumors for treatment of cancer. 
Multifunctional nanocarriers that combine chemotherapy, radiation and drug therapy are 
shaping the future of cancer treatment. These technologies sure move the clinical 
application forward, but the accelerating development should also be in compliance with 
FDA and be promising in innovation. There has been a dearth of research in this regard 
as discussed above. There is a paradigm shift in treatment approaches of passive and 
active treatment of cancer. It will be exciting to know if nanomedicine becomes a mode 
of treatment to improve the longevity of the cancer patients in future.  
 
Biomedical applications  
Various biomedical applications of NPs include use as drug carriers, gene 
delivery, gene therapy, labeling and tracking agents, hyperthermic agents and magnetic 
resonance imaging (MRI) agents. All the applications are based on the chemical 
modification of the nanoparticle surface which defines the biomolecular interactions in 
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vitro or in vivo. Drug delivery has been the most studied platform to launch drug coated 
nanoparticles to achieve localized treatment in vitro and in vivo. Drug delivery systems 
are necessary for increasing the efficacy of biodistribution of the drug (Laurent, Forge et 
al. 2008; Sun, Lee et al. 2008; Berry 2009). Nanoparticles have been used for transport of 
drugs and genes, via passive, active and direct means. This has been attributed to the 
small nature of NPs which allows them to cross cellular barriers/membranes. The 
increased surface area of nanoparticles to volume ratio allows increased loading of drugs 
(Parak, Gerion et al. 2003; Alivisatos 2004). These properties make nanoparticles an 
excellent vehicle for diagnostic and therapeutic uses in biomedical applications. Different 
nanoparticles have been used for imaging. Such studies have shed considerable light and 
shown insight in understand the biochemical processes in vitro and in vivo. The 
photophysical properties of gold nanoparticles have used in sensing, biodiagnostics, 
imaging, sensing, biodetection, treatment of cancer and targeting cancer cell markers. 
Labeling of cellular proteins, cellular tracking, pathogen detection, anti-toxin treatment 
and fluorescence resonance energy transfer (FRET) techniques have taken advantage of 
size, surface plasmon resonance pattern, photophysical properties of nanoparticles 
(Maenosono, Yoshida et al. ; Lyon, Musick et al. 1998; Storhoff, Elghanian et al. 1998; 
Yguerabide and Yguerabide 1998; He, Musick et al. 2000; Zhao, Brook et al. 2008; 
Agasti, Chompoosor et al. 2009; Nam, Won et al. 2009; Xu, Wang et al. 2009; Wang and 
Irudayaraj 2010).   
In conclusion, bionanomaterials have been studied and a great depth of 
biomolecular research has been achieved. But scientists really need to answer the key 
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question - what is the fate of nanoparticles once introduced into the human body system 
for biomedical applications? There has been a shift in the treatment modalities with 
nanotechnology towards specific, targeted, localized and detection mechanisms in 
biomedical applications. There is an increase in the interest of biosensor development, 
biodetection, bioterrorism, nano-chip based innovations, site specific tumor treatment and 
so on and so forth. The basic underlying current of developing these technologies is to 
provide rapid screening methods, specificity, multi-modal treatment approaches, lower 
the cost of patient care, treat infections, fight cancer and hence, engineer therapeutic 
approaches that can increase the life span with quality care treatment. Therefore, use of 
nanotechnology in health care has shown prospective future but there are ethical issues 
associated with the technology that also need attention.  
 
Objectives 
Nanoparticles are unique materials that have been studied extensively since they 
are at nano scale. This allows for larger surface area of the particle to show increased 
range of possible interactions with bio-organic materials that are present on the cell 
surface. The interactions also depend on the methods used for synthesizing the particles, 
their size and their cytotoxic effects in vivo. The main aim of this study was to study and 
compare the different antimicrobial and cytotoxic profiles of commercial nanoparticles 
and green synthetic nanoparticles. The second aim of this investigation sheds light on 
effects of protein corona on cytotoxicity in different cancer cells. Thirdly, this study 
attempts to study the size based differences in uptake of sugar functionalized and plain 
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gold nanoparticles. Once the degree of uptake and cytotoxicity of different kinds of NPs 
based on surface chemistry and size is determined, the last part of this dissertation aims at 
investigating the use of carbohydrate functionalized gold nanoparticles to bring about 
competitive binding in prostate cancer cells in the presence of urinary tract infection 
causing bacteria E. coli ORN178. Overall, this study attempts to investigate the 
cytotoxicity of nanoparticles based on their mechanisms of synthesis, size and surface 
functionalization.  
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CHAPTER TWO 
 
APOPTOSIS INDUCED CELL DEATH BY PROTEIN COATED GOLD AND 
SILVER NANOPARTICLES 
 
 
Introduction  
 
The ability to tailor and engineer nanomaterials with desired physicochemical 
properties has resulted in numerous applications in chemical, biological, and medical 
fields. Particularly, nanomaterials have shown promising solutions for cancer diagnosis, 
therapy, molecular targeting, drug delivery and many other biomedical applications 
(Thakkar, Mhatre et al. 2010). In view of this, the United States National Cancer Institute 
(NCI) launched the ‘Alliance for Nanotechnology in Cancer’ in 2004 to accelerate 
research in cancer nanotechnology and promptly achieve clinical applications. 
Nanoparticles (NPs) are being widely used for oxidative therapy against cancer (Kumar, 
Harrison et al. 2007). NP-based oxidative cancer therapy involves the elimination of free 
oxygen radicals that are involved in multistage carcinogenic process. Any oxidative DNA 
damage by free oxygen radicals and suppressive effects on DNA repair can propel 
carcinogen activation ensuing in tumor promotion (Hu, Dubin et al. 1995). Furthermore, 
oxidative damage can initiate programmed cell death or apoptosis. As a result of 
apoptosis, the DNA machinery is halted due to modifications produced in cell chromatin, 
leading to the release of apoptotic bodies. 
 The reactive oxygen species (ROS) can cause DNA modifications in the histones 
and thereby change the conformation of the DNA-binding sites. As a result, DNA 
molecule is further exposed to oxygen radicals that destabilize the helix leading to cell 
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death (Dizdaroglu 1992). It is clear that there exist a plethora of interrelated mechanisms 
in cancer cells, which can be exploited for employing different treatment strategies. 
Accordingly, various strategies such as chemotherapy, hyperthermia, and radiation 
therapy have been developed (Sudimack and Lee 2000). Many in vitro studies have 
studied the effects of noble metal nanoparticles on apoptosis in order to develop novel NP 
based oxidative therapeutic strategies against cancer.  However, the effects of non-
specific binding of proteins to NPs or NP-surface fouling on apoptosis have not yet been 
well investigated.  
Surface fouling and subsequent formation of so-called ‘protein corona’ can 
mediate the uptake of the NPs via receptor-mediated endocytosis. The main blood plasma 
proteins involved (both directly and indirectly) in surface fouling are albumins, 
fibronectins, complement proteins, fibrinogen, immunoglobulins and apolipoprotein. 
Surface fouling has been found to result in phagocytosis of the nanostructure by 
monocytes/macrophages ultimately promoting an immune response and inflammation. In 
the presence of protein corona, particle-cell interaction depends on the type of coated 
protein(s), electronic charge, and protein-lipid interactions [10-12]. It is well known that 
the adsorption of proteins onto the NP surface occurs mainly due to a gain in 
conformational entropy (DS) due to protein unfolding.  Therefore, any conformational 
changes that occur in the protein upon binding NPs can also cause adverse physiological 
response. In light of this, it is pertinent to study the effects of protein corona formation on 
the physiological response of NPs.  
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Here, the effects of protein corona formation on the physiological response of 
gold and silver NPs (GNPs and AgNPs) in three different cells lines breast (MCF-7), 
colorectal (HT-29), and prostate cancer cells (DU-145) was studied. The dependence of 
physicochemical properties on the formation of albumin and fetal bovine serum protein 
corona using UV-Visible spectrophotometry, dynamic light scattering, and gel 
electrophoresis was investigated. The results indicated that apoptosis is dependent on the 
size of the NPs. More importantly, it was seen that protein corona causes significant 
changes in the induction of apoptosis due to several factors such as reduced surface 
charge, change in protein conformation, and increased agglomeration. 
 
 
Materials and methods 
DU-145 cells were grown in Dulbecco’s modified Eagle’s 100 medium (DMEM) 
modified to contain Earles Balanced Salt Solution, non-essential amino acids, 2 mM L-
glutamine, 1 mM sodium pyruvate, and 1,500 mg/L sodium bicarbonate. It was 
supplemented with fetal bovine serum to a final concentration of 10 %, 100 UI/ml 
penicillin G, and 100 μg/ml streptomycin and the cells were grown in a humidified 
incubator with 5 % at 37 °C. All the media components were purchased from Promega, 
USA. The HT-29 cells were grown in McCoy’s medium (ATCC, USA). The human 
MCF-7 cells were cultured in Eagle's Minimum Essential Medium (ATCC, USA).  
The commercial gold nanoparticles (GNPs): 20 and 80 nm AgNPs and 20 nm 
GNPs were purchased from Ted Pella Inc., USA while 80 nm GNPs were prepared using 
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a laser ablation technique. For ease of discussion, we labeled NPs as X-GNP/X-AgNP 
where X indicates the NP size. All NPs were characterized using a Hitachi H-7600 
transmission electron microscope. 
For studying the effects of protein coated NPs on apoptosis, all NPs were coated 
with Fetal Bovine Serum (FBS) and bovine serum albumin (ALB) using the following 
procedure. All the samples were incubated in ALB or FBS for 1 h at 37°C. Subsequently, 
the samples were washed by centrifuging at 10000 x g for 10 mins. The pellets containing 
protein coated NPs were washed thrice with nanopure water in order to remove any 
loosely bound proteins. Finally, all NPs were re-suspended in nanopure water. SDS-
PAGE was performed for all the samples using a 4-20% gel (Biorad, USA). The gel was 
stained by Coomassie blue stain. A Smart Protein standard (Genscript, USA) was used to 
identify and analyze the presence of BSA and FBS bound to the samples. The 
hydrodynamic sizes of the plain NPs and protein-bound NP samples were measured using 
dynamic light scattering (DLS) using Malvern Zetasizer and UV-Vis spectroscopy 
(Biotek Synergy H2, USA).  
 
Cell death detection ELISA assay 
Apoptosis was measured using a photometric enzyme immunoassay available in 
the Cell Death Detection ELISA kit (Roche chemicals, USA). Briefly, the kit is an in 
vitro technique to measures the cytoplasmic histone-associated DNA fragments (mono- 
and oligonucleosomes) after induced cell death. The anti-histone antibody reacts with the 
histones H1, H2A, H2B, H3 and H4. Addition of anti-DNA peroxidase binds to single 
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and double-stranded DNA. Hence, the ELISA allows the detection of mono and 
oligonucleosomes by measuring the optical absorbance at 405 nm. For all the studies, 
cells were diluted with culture medium to obtain a 1 x 105 cells/ml concentration in a 96-
well plate. Samples containing the commercial plain 20 nm GNPs, 20 nm AgNPs, 80 nm 
GNPs and 80 AgNPs and the corresponding protein coated (FBS & ALB) NPs were 
added to the cells. The 96- well plates were incubated for 24 h. The cells were then 
centrifuged at 200 x g for 5 min. After discarding the supernatant the cell pellet was 
resuspended in cell culture medium. 
 
Statistical analysis 
 All experiments were carried out in triplicates with results expressed as 
mean±standard error. Statistically significant differences were calculated using the two-
tailed unpaired one-way analysis of  ariance (ANOVA) with p  alues of ≤0.05, <0.01, 
and <0.001 considered significant using Prism 5.0 (GraphPad Software, CA, USA).  
 
 
Results  
Characterization of NPs 
As shown in Figure 2.1, the TEM images clearly showed that all the NPs 
exhibited spherical shape with a well-defined diameter. Further, the DLS studies 
indicated that the hydrodynamic size of NPs was slightly higher than the dehydrated 
diameter obtained from TEM. All the pristine NP suspensions exhibited high zeta 
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potential suggesting long-term stability (Table 2.1 and 2.2). Upon protein coating, the 
hydrodynamic size of all the NPs increased at least by ~10 nm. Furthermore, FBS coating 
resulted in a higher increase in hydrodynamic size compared to ALB possibly due to the 
adsorption of multiple proteins. The magnitude of zeta potential of protein coated NPs 
decreased considerably indicating that the NPs agglomerate more rapidly due to the 
formation of protein corona.  
The UV-Vis absorption spectra displayed the characteristic surface plasmon 
resonance peak (SPR) at ~520-550 nm for GNPs and 400-420 nm for AgNPs (Figure 
2.2). Interestingly, the SPR peak showed an evident upshift for all the protein coated NPs. 
Such an observation may be interpreted as follows. In metal NPs, the characteristic peak 
of SPR is dependent on the size, shape, and dielectric function (ε) of the NPs and its 
surrounding medium. The interaction of GNPs/AgNPs with protein molecules resulted in 
a further change of ε leading to an upshift in the extinction coefficient maximum and the 
SPR peaks. 
The percentage of apoptosis caused by 20-GNPs and 80-GNPs are depicted in 
Figure 2.3. It was seen that 20-GNPs caused significant (P<0.001) apoptosis in MCF-7 
and DU-145 cells when compared to HT-29 cells.  The protein coated 20-GNPs in 
general indicated decrease in the percentage of apoptotic cells in MCF-7 cells when 
compared plain 20-GNPs (Figure 2.3a). On the other hand, 80-GNPs caused significant 
cytotoxicity in DU-145 cells compared to MCF-7 and HT-29 cells (Figure 2.3b). 
Significant apoptosis was characteristically higher in MCF-7 and DU-145 cells when 
compared to the HT-29 cells.  
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     Figure 2.1. TEM micrographs of GNPs and AgNPs 
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Figure 2.2. UV-Vis absorption spectra of plain, ALB and FBS bound GNPs and AgNPs 
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                  Table 2.1. DLS measurements of GNPs 
 
 
       Table 2.2. DLS measurements of AgNPs 
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The ALB-80-GNPs caused 20% apoptosis in MCF-7 and DU-145 cells than FBS-
80-GNPs that caused significant apoptosis of about 25% in MCF-7 cells and only 8% 
cytotoxicity in DU-145 cells. It is interesting to note that the HT-29 cells did show 
significantly low apoptotic cells when treated with ALB/FBS-80-GNPs (Figure 2.3b). 
 
Effect of protein corona on apoptosis 
As shown in Figure 2.4 the 20-AgNPs and 80-AgNPs showed significant 
(P<0.001) cytotoxic effects in MCF-7 and DU-145 cells. The MCF-7 cells had 
significantly higher levels of apoptosis when treated with 20/80-AgNPs and as well as 
20/80-ALB-AgNPs when compared to DU-145 and HT-29 cells (Figure 2.4a&b). In case 
of HT-29 cells, there was a significant decrease in cytotoxicity when the cells were 
treated with plain AgNPs and FBS-AgNPs. Interestingly the 80-AgNPs brought about 
higher cytotoxicity than the 20-AgNPs. On the contrary, the FBS-80-AgNPs exhibited 
higher apoptosis in DU-145 cells when compared to ALB-80-AgNPs (Figure 2.4b).  
The plain 80-GNPs showed significant apoptotic effects in HT-29 and DU-145 
cells rather than the multi-drug resistant (MDR) MCF-7 cells.  
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Figure 2.3. Induction of apoptosis by as measured by Cell Death Detection ELISA in the 
presence of GNPs 
 
 
 
Figure 2.4. Induction of apoptosis by as measured by Cell Death Detection ELISA in the 
presence of AgNPs 
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Discussion 
Nanoparticles have been shown to enter the cell and often tend to accumulate in 
various parts of the cellular components depending on their route of entry. Particles of 
30-80 nm in particular not only enter the cellular components but also elicit endocytosis  
that often results in a cascading chain reaction that leads the cell to shut down its 
machinery (Podila and Brown 2013). The nuclear entry of mono-dispersed NPs through 
the nuclear pore has been demonstrated and attributed to the onset of reactive oxygen 
species resulting ultimately in DNA damage (Heller and Heller 2006). This DNA damage 
is an important factor in cancer treatment. The propensity for cancer has been linked to 
apoptosis, followed by chromatin condensation, pyknosis, nuclear membrane blebbing 
and ultimately fragmentation of cell into apoptotic bodies. The aim of this investigation 
was to study the stability of plain and protein coated NPs, their biocompatibility and 
measure the amount of DNA damage in terms of apoptosis by using a cell death detection 
ELISA kit. 
The plain and the ALB/FBS coated NPs were found to be stable. The zeta 
potential values of the protein coated NPs indicated aggregation due to protein corona. 
The TEM micrographs confirmed spherical NPs. The DLS measurements showed an 
increase in the hydrodynamic size of the protein coated NPs. The cell death detection 
ELISA showed interesting results. The plain GNPs and AgNPs showed significant 
apoptosis in MCF-7 cells compared to HT-29 and DU-145 cells. The effect of protein 
corona showed significant apoptosis in MCF-7 and DU-145 cells. The surface chemistry 
of the NPs is important for nanoparticles-cell interactions. In this study we used 
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commercial NPs that are citrate capped and GNPs synthesized by laser ablation. Studies 
have shown even though citrate functionalized GNPs do not bring about reduction in 
MCF-7, buy they induced apoptosis in lung cancer cells.  
However, the number of apoptotic cells was found to increase as the 
concentration of citrate capped GNPs was increased (Mohan, Praveen et al. 2013). Selim 
et al. (2012) showed that GNPs caused cytotoxicity by inducing significant upregulation 
of p53, bax, caspase-3 & caspase-9 in MCF-7 cells (Selim and Hendi 2012). On the other 
hand, it has been demonstrated that 20-30 nm GNPs synthesized by laser ablation were 
completely non-toxic to pancreatic cancer cells after 24 h of exposure. However, they 
were found to enter cells and reach the cytoplasm by endocytosis without any surface 
modification (Sobhan, Sreenivasan et al. 2012). Katsnelson et al. (2013) used nanogold 
and nanosilver of 50 nm prepared by laser ablation process in water to demonstrate both 
the particles were significantly bioactive in pulmonary phagocytosis in rats (Katsnelson, 
Privalova et al. 2013). They also demonstrated that nanosilver compared to nanogold 
caused enhanced toxicity and genotoxicity which was measured in histological specimens 
of spleen, kidney and liver of rats. Also, there is vast evidence that AgNPs can enter the 
systemic circulation and cause cytotoxic effects such as hepatotoxicity and induce 
inflammatory effects (Park, Neigh et al. 2011). Many studies have demonstrated that 
AgNPs are capable of inducing apoptosis, causing membrane damage resulting in cell 
death and releasing oxygen reactive species (Rani et al. 2009). The ability for the AgNPs 
to degrade internally in a cell and release Ag ions has been attributed to the ability of 
these particles to induce cell death. This intracellular release of Ag ions is responsible in 
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eliciting cytotoxic effects that cause apoptosis. Singh and Ramarao (2012) demonstrated 
that AgNPs were taken up by phagocytosis in murine macrophages and were found to be 
localized in the cytoplasm. They also reported that the AgNPs induced apoptosis because 
of the intracellular dissolution of Ag ions which was 50 times faster than in water (Singh 
and Ramarao 2012).  
Many studies of targeted nuclear delivery of NPs have exploited the protein 
corona to determine the biokinetics of the conjugated particles in biological systems 
(Schaffler, Semmler-Behnke et al. 2013). It has been shown that smaller NPs have more 
proteins coated due to their large surface area. However, as size increases, less protein is 
bound to its surface(Mirshafiee, Mahmoudi et al. 2013). Not only does the protein corona 
mask the NP and make it inaccessible to the cell while being endocytosed it also causes 
NPs coated with protein to prevent agglomeration when the protein is stable and 
uniformly charged (Schaffler, Semmler-Behnke et al. 2013). The zeta potential values in 
this study have shown increase in net surface charge there by indicating more protein 
bound to the NPs. FBS compared to ALB is a complex serum consisting of multiple 
proteins when compared to ALB. The DLS measurements indicate that the FBS coated 
NPs were of relatively higher hydrodynamic size when compared to the ALB coated NPs. 
This could be attributed to the composition of the proteins in FBS that are also found in 
plasma. Capriotti et al. (2013) have shown that polyanionic DNA is associated to the 
lipoplex surface and can interact with basic plasma proteins (Capriotti, Caracciolo et al. 
2011; Capriotti, Caracciolo et al. 2011; Caracciolo, Pozzi et al. 2011). Protein 
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functionalized GNPs have been successfully shown as a tunable platform for specific 
binding to prostate cancer cells (Kasten, Liu et al. 2013).  
In this investigation bigger sized plain 80-GNPs did enhance toxic effects in DU-
145 cells when compared to 20-GNPs and 20/80nm AgNPs. It was also seen that the 
percentage of apoptosis was significantly low in HT-29 cells compared to the MCF-7 and 
DU-145 cells when they were treated with ALB-80-GNPs. On the other hand, FBS-80-
GNPs induced significantly higher levels of apoptosis in MCF-7 cells when compared to 
the commercial NPs. This difference in apoptosis could be attributed to the different 
lengths of the protein ALB and FBS coated to the NP.  The protein chain that is readily 
accessible to the cell environment can undergo conformational changes in its secondary 
structures and bring about different biomolecular interactions by means of electron 
charge transfer and destabilize the cellular components by initiating different downstream 
processes. 
The charge variation does not only destruct the interaction between the drugs and 
the carriers, but also cause the disassembly of the carriers themselves. Hence, there is a 
need to develop vectors that trigger the release of the drug inside the cells than outside 
the cells. Gene therapy not only involves delivering such a mutant that attacks the basic 
DNA machinery by using the cancer cells as its basis of treatment but alternatively can 
also be introduced in a vector to bring about a desired effect by controlled release in a 
tumor  (Alexis, Rhee et al. 2008). Advances in apoptotic research have shown that 
protein coated NPs are less susceptible to cause cytotoxic effects in cells when compared 
to bare NPs (Podila, Vedantam et al. 2012; Vedantam, Huang et al. 2013). The protein 
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corona has served as a mask for the NPs to escape endocytic digestion, makes the NPs 
biocompatible due to conformational changes  and enhances stability of the NP in the 
cancer cell, makes the NPs a good vector to enter the cells and cause desired release of 
drugs and lastly, brings about synergistic effects in treatment modalities (Lundqvist, 
Stigler et al. 2011; Podila and Brown 2013). The ALB/FBS 80-AgNPs interestingly 
caused high levels of apoptotic cells in MCF-7 and DU-145 cells than HT-29 cells. 
Hence, these particles can be differentially introduced in the cancer cells to bring about 
cell death. The 80-GNPs show promising future when used as a vector for gene therapy 
in a tumor. The protein coated NPs can be used as a vector for drug delivery for drugs 
like DOX and Palitaxel in cancer cells, which could successfully enter a cancer cell and 
initiate a controlled release. Therefore, not only they can be used for targeted therapy but 
also not trigger higher levels of apoptotic cells, which ensures the therapeutic effect in the 
cancer cells.  
In conclusion two different kinds of NPS that were synthesized commercially and 
by laser ablation method were studied. The NPs were coated with ALB and FBS to study 
the effect of protein corona in the MCF-7, HT-29 and DU-145 cells. The increase or 
decrease of percentage of apoptotic cells caused by the different NPs was measured. Cell 
death was measured colorimetrically detecting the extent of DNA damage caused by the 
modifications in conformational changes in histones. It was evident that the laser ablation 
particles caused significantly different levels of apoptosis in the three cells lines when 
compared to the commercially synthesized citrate capped GNPs and AgNPs. Also the 
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laser ablation particles show potentially futuristic use in cancer therapy and biomedical 
applications by exploiting their unique chemically active surface chemistry.  
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CHAPTER THREE 
 
SYNERGISTIC COLLUSION OF GREEN SYNTHESIS NANOPARTICLES WITH 
ANTIBIOTICS AS EFFECTIVE PHARMACOLOGICAL AGENTS 
 
Introduction 
The field of nanotechnology is progressing at a rapid rate due to the remarkable 
potential of nanomaterials for numerous applications (Mukherjee, Sushma et al. 2012). 
The ability to manufacture a wide variety of nanomaterials presents us with vast 
opportunities for bio-medical applications such as drug and gene delivery (Nune, Gunda 
et al. 2009). Currently, wet chemical synthesis techniques are being widely used for 
producing metal nanoparticles mainly due to their simplicity, high growth rate and 
throughput. These chemical methods extensively employ hazardous organic reagents that 
can result in adverse biological response in living organisms, and the environment at 
large.  Therefore, researchers have begun to replace harsh chemical synthetic procedures 
with clean, non-toxic and en ironmentally acceptable ‘‘green chemistry’’ methods.  In 
green synthesis methods, NPs are synthesized using an environmentally benign solvent, 
eco-friendly reducing and natural capping agents. In the last five years, many researchers 
have utilized extracts from biological systems such as microorganisms and plants to 
produce metal NPs. Importantly, the use of plant biomass and extracts has gained much 
popularity over other biological green methods due to its simplicity, ready scalability, and 
low reaction time.  
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Thus far, green extracts from neem leaf, geranium, lemongrass, tamarind, Aloe 
vera and many other plants have been used to synthesize noble metal NPs with varying 
shapes, sizes, and core-shell structure. These green extracts are known to contain such 
phytochemicals as terpenoids, flavonoids, phenol derivatives, di-hydric phenols that can 
mimic reducing and capping agents (Jha, Prasad et al. 2009; Ahmad, Sharma et al. 2010; 
Kumar, Yadav et al. 2010). The main advantage of green synthesis NPs is that there is no 
need for artificial chemical stabilizing agents, external heat or any other active process. 
For example, Au NPs synthesized using wet chemical method often use heat, stirring, and 
citrate functional groups for producing stable aqueous suspension. In contrast, green 
synthesis NPs are naturally coated with phytochemicals that lend them high surface 
charge required for achieving a stable aqueous suspension. The presence of such 
phytochemicals on the NP surface could then be used to achieve antimicrobial action 
from NPs. While there has been much focus on utilizing NPs directly as antimicrobial 
agents, a concomitant need for highly efficient, broad-spectrum drugs demands a NP-
biomedical drug composite that can treat multi-drug resistant bacteria (Jagajjanani Rao 
and Paria 2013). To this end, we prepared NP-drug composites and investigated the 
synergistic effects of noble metal NPs on the antimicrobial activity of traditional drugs.  
Biogenic Ag and Au NPs were synthesized using the floral extract of Tecoma 
stans and Tagetes erectus. Tecoma stans has been known for its anti-inflammatory, 
antimicrobial, antifungal, antispasmodic and cytotoxic activities and has been considered 
as a potent curative for diabetes mellitus (Vijay Singh 2011; V 2012). On the other hand 
Tagetes erecta has been used in the treatment of eye diseases, rheumatism, cough, 
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bleeding piles, and ulcers and is known for its insecticidal properties. The phytochemical 
content of these flowers is known for its potent antimicrobial and cytotoxic activity and 
has been found to be high in antioxidant activity (Hadden, Watkins et al. 1999; Bashir 
and Gilani 2008; Basavaraj V Chivde 2011; Nikkon, Habib et al. 2011).  
This study utilizes green synthesis noble metal NPs to ameliorate the strength of 
traditional such antimicrobial drugs as Vancomycin, tetracycline and ampicillin. 
Interestingly, it was observed that the biogenic NPs act synergistically with the standard 
drugs albeit their inherent low antibacterial activity. Synergistic effects in terms of drug-
NP interactions and NP catalysis was observed. Results suggest that the biogenic NP-
drug composite could open new avenues for the development of drugs for multi-drug 
resistant bacteria.  
 
 
Materials and methods 
Silver nitrate (AgNO3) 3and Chloroauric acid (HAuCl4.3H2O) were procured 
from Sigma-Aldrich chemicals and were used without any further purification. Fully 
blossomed flowers of Tecoma stans and Tagetes erecta were collected from the 
university garden (Figure 3.1). 
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Figure 3.1. Floral images of a) Tagetes erecta and b) Tecoma stans 
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Preparation of the floral extract 
In the first step, flowers of Tecoma stans and Tagetes erecta were collected, 
washed and cleansed with de-ionized water. One gram of the flower petals were added to 
10 ml of millipore water and the mixture was refluxed for 10 minutes at room 
temperature. The mixture was then filtered using a macro porous Whatman filter paper. 
Subsequently, the extract was centrifuged at 4500-5000 rpm for 15 min and the 
supernatant was used for synthesis of silver and gold nanoparticles. The extract was used 
within 5 hours of its preparation, to maintain its activity and for the reproducibility of the 
results. 
 
Bio-synthesis of Ag and Au nanoparticles using the extracts 
Various amounts (0.5 ml - 2.5 ml) of floral extracts were added to 2.5 ml (2mM) 
AgNO3 solution. In all our experiments, the total volume of the solutions was maintained 
at 5 ml by adding millipore water.  The solution was then allowed to stand quiescently for 
24 hrs. After 24 hrs, the solution was centrifuged at 6000 rpm for 10 min and the 
supernatant containing extract was removed and, the pellet was re-suspended in 3 ml 
millipore water. This process was repeated three times. In the final step, the pellet was re-
suspended in 1 ml of millipore water to get a relatively more concentrated and pure 
colloidal solution of silver nanoparticles. For the synthesis of gold nanoparticles, the 
same procedure was followed but with HAuCl4.3H2O.  
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Characterization of nanoparticles 
AgNPs and GNPs were characterized using transmission electron microscopy, 
UV-Vis spectroscopy and dynamic light scattering measurements. All UV spectra were 
recorded on a Shimadzu 2450 PC UV-Vis spectrophotometer. The hydrodynamic size 
and zeta potential were determined by using Brookhaven Particle Analyzer 90 
instrument. The shape and size distribution were determined using transmission electron 
microscope - Hitachi H 7600 instrument operated at an accelerating voltage of 75-120 
kV. The nanoparticles obtained from the Tecoma stans was referred as sample AgNP-TS 
and GNP-TS. The nanoparticles obtained from Tagetes erecta was labeled as AgNP-TE 
and GNP-TE respectively. 
 
Antimicrobial activity 
The microorganisms Staphylococcus aureus ATCC 25923, Enterococcus faecalis 
and Escherichia coli DH5α SK+ were used for the investigation of anti-microbial 
activity. Vancomycin, Ampicillin and Tetracycline were the standard antibiotics of 
choice. The zones of inhibition (ZOI) were obtained using disk diffusion assay (DDA). 
For DDA, overnight cultures of bacterial strains E. faecalis, S. aureus ATCC 25923 and 
E. coli DH5α SK+ were washed with sterile saline. The optical density was ad usted to 
0.122 (1 x 10
7
 cells/ml). Spread plating of a 100 µl aliquot of the cultures was performed 
on Tryptic Soy Agar plates (TSA). After plating the three bacteria, antibiotic discs TE 
(Tetracycline 30 µg/ml), VA (Vancomycin 30 µg/ml) and AM (Ampicillin 10 µg/ml) 
were dipped in the respective extracts and placed on the TSA plates. In addition to that, a 
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plain disc dipped in plain extract (E) containing nanoparticles (Au and Ag) was placed on 
the plates. The plates were incubated at 37°C overnight. The zones of inhibition were 
measured and compared to the TSA plate containing the antibiotic discs that were not 
dipped in the extract which served as a standard. The diameter of the commercial 
antibiotic discs (6 mm) was nullified from the measured zones of inhibition. This way the 
synergistic effect of the extract on the antibiotic discs on the three different pathogens 
was analyzed.  
 
Cytotoxic effects of green synthetic particles 
The cytotoxic effect of the samples on human colorectal adenocarcinoma cells 
(HT-29) and human breast cancer cells (MCF-7) cell lines was investigated. The cell 
lines were purchased from ATCC, USA. The cells were cultured in McCoy’s medium 
(HT-29) and Eagle’s modified medium (MCF-7) procured from ATCC, USA. The cell 
lines were maintained in a humidified incubator with 5 % at 37 °C.  
Both the cells lines were seeded (1×10
5
 cells/well) into a 96-well plate and 
incubated at 37°C overnight to allow the cells to adhere to the 96-well plate. Both the cell 
lines were exposed to the GNP-TS/TE and AgNP-TS/TE at 1:4 ratios. The plates were 
further incubated for 24 h at 37°C. After exposure of the nanoparticles to the two 
difference cell lines, the membrane cytotoxicity/damage was determined by the release of 
lactate dehydrogenase (LDH) from cells with a damaged membrane using the CytoTox-
ONE™ Homogeneous Membrane Integrity Assay  it from Promega, USA. Briefly, the 
cytotoxicity of the particles is measured by amount of leakage of cell components from 
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cytoplasm into the surrounding culture medium, indicating the number of nonviable cells. 
The assay essentially measures the release of LDH into the culture medium due to the 
enzymatic coupling that converts the substrate resazurin to resorufin. This rapid assay 
hence, directly measures the LDH released in assay wells without damaging the healthy 
cells. 
Statistical analysis 
All experiments were carried out in triplicates with results expressed as 
mean±standard error. Statistically significant differences were calculated one-way 
analysis of  ariance (ANOVA) with p  alues of ≤0.05 and <0.001 considered significant 
using Prism 5.0 (GraphPad Software, CA, USA). 
 
 
Results and discussion 
Characterization of biogenic nanoparticles 
Figure 3.2 shows the time evolution of surface plasmon resonance (SPR) peak 
from AgNPs (or GNPs) formed during the reaction between AgNO3 (or HAuCl4) in the 
presence of Tecoma stans and Tagetes erecta extracts. A clear surface plasmon resonance 
(SPR) peak at 430 nm (for AgNPs) and 540 nm (for GNPs) suggests that the salts are 
effectively reduced by the floral extracts to form AgNPs and GNPs. As evident from 
Figure 3.2, the SPR peak intensity saturated within 90 mins implying the completion of 
reaction or formation of NPs. Clearly, the SPR intensity increases very rapidly for GNPs 
compared to AgNPs for both the extracts. Such an observation concurs with the 
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difference in the reduction potential of Au and Ag. The reduction of Ag salts is expected 
to be more difficult and slower than Au NPs due to their lower reduction potential (Ag+ 
/Ag0  = 0.80 V and Au3+ /Au0 = 1.50 V versus SCE). 
 
The detailed electron microscopy studies revealed that both Ag and GNPs are 
spherical in shape with a size ~30-40 nm (Figure 3.3). However, the light scattering 
experiments showed that the NPs agglomerated with mean sizes larger than the 
dehydrated size, as indicated by TEM (see Table 3.1). This could be possibly attributed 
low zeta potential arising from the lack of capping agents in our synthesis procedure. 
Nonetheless, we observed that the AgNPs and GNPs from both the extracts formed 
relatively stable aqueous suspension due to the presence of flavonones and terpenoids on 
the surface of NPs. In the absence of other strong ligating agents, flavonones or 
terpenoids could be adsorbed on the surface of NPs possibly by interaction through 
carbonyl groups or π –electrons.  
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Figure 3.2. The time evolution of surface plasmon resonance peak during the 
formation of AgNP and GNP in the presence of Tacoma stans and Tagetus erecta.  
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 Figure 3.3: Typical transmission electron micrograph of AgNPs prepared using Tacoma 
Stans (a) and GNPs prepared using Tagetus erecta (b) show that NPs exhibited spherical 
shape with a mean size ~30-40 nm. The inset shows lattice planes of individual NPs 
suggesting that the samples are highly crystalline. 
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Table 3.1 Hydrodynamic size distribution and zeta-potentials of biogenic nanoparticles 
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Antimicrobial activity 
 
The zones of inhibition (ZOI) in the disc diffusion assay for the three select 
pathogenic bacteria with respect to AgNPs and GNPs synthesized from both floral 
extracts are shown in Figure 3.4. In case of AgNP- TS, there was a significant increase 
(p<0.001) in the ZOI for AE (Ampicillin dipped in extract) against E. coli when 
compared to the standard Ampicllin. The same trend was also observed in case of AgNP-
TE. A significant increase (p<0.001) in ZOI by was also observed in case of TE 
(Tetracycline dipped in extract) against E. faecalis when compared to the standard 
antibiotic The AgNPs did not however show significant increase in ZOIs in case of other 
treatments against the select pathogenic microorganisms. 
 
The GNP-TS showed significant increase (p<0.001) in ZOI for Vancomycin disc 
dipped in extract only against E. coli whereas a significant increase (p<0.001) in ZOI for 
Tetracycline dipped in extract against E. faecalis was observed when compared to the 
ZOI of the plain antibiotic disc. The same trend was also observed with respect to GNP-
TS (Figure 3.4). Interestingly, GNP-TE showed significant increase (p<0.001) in the ZOI 
for AE (Ampicillin dipped in extract) against E. coli when compared to GNP-TS.  
On the whole, there was a very small ZOI by the plain extract against the three 
pathogens. The extracts containing AgNPs and GNPs did enhance the antimicrobial 
activity of the antibiotic by increase of zones of inhibition by different percentages 
against the select pathogens. There seems to be a synergistic effect that brings about 
increase in the diameter of ZOIs against the three pathogens. On the contrary it was also 
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observed that in some instances the antibiotic discs dipped in extract showed significant 
decrease in ZOI when compared to the standard antibiotics.  
As mentioned earlier, three standard antibiotic discs (Vancomycin, Tetracycline 
and Ampicillin) to test the synergistic effects of biogenic nanoparticles. Vancomycin and 
Ampicillin drugs inhibit the proper cell wall synthesis of bacteria. However, the 
mechanism of action in Vancomycin limits it to be effective only in gram-positive 
bacteria while Ampicillin is an effective for both gram-positive and negative bacteria. 
Tetracycline is a broad-spectrum antibiotic that hampers bacterial cell growth by 
inhibiting the translational process. For example studies have shown that biosynthetic 
AgNPs from Hypnea sp. are more bactericidal against gram-positive (S. aureus) and 
gram-negative bacteria (E. coli) isolated from wound specimens. (Devi and Bhimba 
2012).  AgNP-TS extract by itself had antimicrobial effects against the three pathogens 
whereas the GNP-TS extract did not have any effect at all (Figure 3.4). The AgNP-TE 
extract exhibited antimicrobial activity only against E. coli and S. aureus and not against 
E. faecalis. The GNP-TE extract did not show any antimicrobial activity against all the 
three pathogens.  
The extract exhibited antagonist and synergistic effects along with the antibiotic 
discs against the three pathogens. The AgNP-TS/TE showed the antibiotic effect was 
enhanced in case of Tetracycline and Ampicillin whereas antagonistic effect was seen in 
case of Vancomycin when used with extract (Figure 3.5). In case of the GNP-TS the 
antibiotic effect was enhanced. However, decrease of antimicrobial activity was observed 
in case of Vancomycin and Tetracycline against E. coli and E. faecalis. Interestingly, no 
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zone of inhibition was observed in case of Ampicillin against E. coli but there was a zone 
of inhibition against E. coli with Ampicillin disc dipped in the GNP-TE extract. This 
phenomenon is indicative of the fact that there is some sort of interference in the 
mechanism of action of the antibiotic disc against the pathogens in presence of the extract 
that synergistically enhances or antagonistically decreases the activity of the drug. The 
synergistic effects of the extracts containing nanoparticles could be due to the presence of 
the various phytochemicals. Overall bio-synthetic nanoparticles hence, showed anti-
bacterial activity against gram positive bacteria (E. faecalis, S. aureus ATCC 25923) as 
well as gram negative bacteria (E. coli).  
In case of Tagetes erecta, the anti-bacterial activity may be due to the presence of 
flavanoids and terpenoids  (Basavaraj V Chivde 2011). The antimicrobial activity of 
extract of Tecoma stans can be attributed to the presence of alkaloids, phenols and 
tannins that are high in phenol content (Vijay Singh 2011; V 2012). 
 
Cytotoxicity of biogenic nanoparticles 
The AgNPs and GNPs from the two different flowers did not show any significant 
cytotoxicity against HT-29 cells. However, AgNP-TE showed significant cytotoxicity (P 
< 0.001) when compared to other samples (Figure 3.5). Interestingly, AgNP-TS 
significant (P < 0.05) cytotoxicity when compared to the GNP-TS extracted from the 
same flower.  On the whole there was no significant cytotoxicity from the particles from 
both flowers against HT-29 cells, exhibited significant membrane damage in MCF-7 
cells. Such anti-cancer effects can be used to develop nano drug carriers for treatment of 
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specific cancer cells. Hence, the GNP-TS/TE did not show any significant membrane 
damage in HT-29 cells. Whereas, the AgNP-TS did bring about significant cytotoxicity in 
MCF-7 cells when compared to the GNP-TS from the same extract of Tecoma stans. It is 
however necessary to purify the sample further and quantify the number of nanoparticles 
per ml, which will shed more light on the antimicrobial activity and cytotoxicity. Since 
the biosynthesis did not involve chemicals, the particles could be further purified and 
potentially used in medical and biomedical applications. 
In addition to that it has been shown that flavonoids of the flavone, flavonol, 
flavanone, and isoflavone classes exhibit anti-proliferative effects in HT-29 and various 
cancer cell lines. The chemical composition in most cases dictates the mechanism of 
induction of apoptosis (Kuntz, Wenzel et al. 1999). Singh et al. have shown that the 
biogenic GNPs synthesized from lemon grass can be internalized by cells and reach the 
cytoplasm (Singh, Shukla et al. 2011). 
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Figure. 3.4 Histograms showing the Zones of Inhibition against pathogenic bacteria in 
the presence of antibiotics loaded with AgNPs and GNPs synthesized using the floral 
extracts of Tecoma stans  and Tagetes erecta  
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Figure. 3.5  Effect of membrane damage by biogenic nanoparticles against a) HT-
29 cells b)   MCF-7 cells *p<0.05, ***p<0.001 
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It is interesting to note that they had biogenic nanotriangles unlike mono-
dispersed spherical particles. It not only shows that the nanoparticles synthesized from 
biosynthesis methods not only can be used as drug carriers and vectors but they are also 
biocompatible. In a recent study it was seen that biogenic AgNPs showed cytotoxic 
effects against MCF-7 cells by bringing about an induction of apoptosis and cell 
membrane integrity (Jeyaraj, Sathishkumar et al. 2013). Devi et al. have shown 
significant cytotoxicity against HT-29 cells by biogenic AgNPs synthesized from 
attributing to the presence of alkaloids present in extract Hypnea sp. (Devi and Bhimba 
2012). 
In order to cause cytotoxic effects the surface particles properties play a crucial 
role in dictating the fate of the biogenic particles in biological systems. GNPs have found 
to exhibit low core toxicity in general. The surface monolayer decides the ability to 
parametrically control the particle’s surface properties which can be used as efficient 
vectors in biomedicine (Rana, Bajaj et al. 2012).  
Theoretically the diameter calculated from the TEM images indicates the diameter 
of the particle in stable position and only of the inorganic core of the particle. Hence, the 
hydrodynamic size on the other hand is bigger. However, it is the hydrodynamic size 
which is an important parameter that also determines the biological activity of the particle 
in in vitro systems. But since the particles are not completely mono-dispersed and 
uniform in nature it will be interesting to investigate further more in optimizing size-
dependent synthesis that will result in more defined particles that can be of significant use 
in biological applications. The antimicrobial properties of the particles however show 
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promising results suggesting that if controlled size-dependent synthesis of these particles 
can be achieved then they can be used for specific antimicrobial applications.  
In summary, silver and gold nanoparticles on time scales faster than the 
conventional methods using the floral extracts of Tecoma stans and Tagetes erecta were 
synthesized. The nanoparticles obtained were largely spherical and mono-disperse with 
diameters in the range of ~25nm. Importantly, the nanoparticles can be tuned to the 
desired geometry by altering the extract concentration. Furthermore, these bio-genic 
nanoparticles were used to test their antimicrobial activity against pathogenic organisms 
S. aureus, E. faecalis and E.coli. The enhanced antimicrobial activity can largely be 
attributed due to the bio-genic nature and catalytic properties of the extract. Even though 
the particles did not show pronounced cytotoxic effects against HT-29 cells, the extracts 
were found to have significant effect in reduction of MCF-7.  
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CHAPTER FOUR 
 
SIZE-DEPENDENT CELLULAR TOXICITY AND UPTAKE OF COMMERICAL 
COLLOIDAL GOLD NANOPARTICLES 
 
 
Introduction 
The estimated risk of prostate cancer is 21% and the lifetime risk of death is 2-
5%. Even though it can be diagnosed early and therapy can be started immediately, 
patients developing metastatic conditions die. Apart from the potent issue of cancer, 
recurrent UTI is one of the most prevalent symptoms (Klein and Thompson 2012). 
Escherichia coli ORN178 are the most common cause of UTI in humans. Various 
urovirulence factors of E. coli ORN178 have been identified such as molecular biology of 
surface receptors of the urothelial cells of the urinary tract, the adhesin specificity and 
primarily and the Type 1 fimbriae associated with the organism (Sokurenko, Chesnokova 
et al. 1997). Detection, diagnosis and treatment of UTI play an important role in prostate 
cancer. One of the novel tools currently vastly studied are nanoparticles. Nanoparticles 
continue to be used as carriers for localized drug diffusion to treat  and detect infections 
and diseases like cancer (P.C. Chen, S.C. Mwakwari et al. 2008).  
Owing to their nano size it is easy for these particles to diffuse into the cells and 
effect desired responses in treatment of diseases. However, the size, type and surface 
charges of the particles play a vital role. Of the different kind of nanoparticles GNPs have 
been extensively studied in this regard. It has been shown that E. coli ORN178 binds 
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specifically to D-mannose, which is an integral part of the glycoproteins that are a part of 
the adhesive domain on host cells (Sharon 2006). The fimbriae of the uropathogenic E. 
coli ORN178 bind to the urolapkins on the surface of urothelial cells of the human 
bladder. We have demonstrated D-mannose functionalized 200 nm GNPs bind 
specifically to E. coli ORN178 (Vedantam, Tzeng et al. 2012). Continuing in the same 
direction in this study we attempt to see if GNPs can be used as specific biodiagnostic 
tool to detect and treat UTI in prostate cancer cells (DU-145).  
This study investigates the binding time of E. coli ORN178 and E. coli ORN208 
to DU-145 cells. It has been shown that E. coli ORN178 binds specifically to D-mannose 
only and E. coli ORN208 serves as a negative control as it has Type 1 pili that fail to bind 
to D-mannose. In order to study the cytotoxicity of plain and functionalized 20 nm and 
200 nm GNPs to DU-145, growth curve of the prostate cancer cells was done. 
Cytotoxicity tests in log and lag phase were performed to study their biocompatibility in 
vitro. Cellular uptake of GNPs was estimated and protein corona of GNPs was studied.  
 
 
Materials and methods 
Cells and strains 
The strains E. coli ORN178 and 208 were provided by Dr. Chu-Cheng Lin, 
Department of Zoology, National Taiwan Normal University and were transformed with 
plasmid pGREEN by electroporation (Sambrook and Russell 2001). Two different GNPs: 
20 nm and 200 nm were purchased from Ted Pella Inc., USA. The concentration of 20 
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nm GNPs was 7×10
11
 particles/ml and 200 nm GNPs was 7×10
8
 particles/ml. The sugar 
D-mannan (Mn) was purchased from VWR (USA). The sugar was dissolved in 0.3 M 
sodium phosphate buffer. Surface functionalization of GNPs with the Mn was carried out 
by a modified multistep procedure (Aslan, Lakowicz et al. 2004; Vedantam, Tzeng et al. 
2012).  All chemicals required for functionalizing GNPs were purchased from VWR, 
USA.  
Human prostate carcinoma cell line DU-145 was graciously given by Dr Arun 
Sree umar, Baylor College of Medicine, Houston, Texas. Dulbecco’s modified Eagle’s 
medium (DMEM) was modified to contain Earles Balanced Salt Solution, non-essential 
amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate, and 1500 mg/L sodium 
bicarbonate. It was supplemented with fetal bovine serum to a final concentration of 
10%, 100 UI/ml penicillin G, and 100 μg/ml streptomycin in a humidified incubator with 
5% at 37°C. All the media components were purchased from Promega, USA. 
 
Binding of E. coli to DU-145 cells 
An eight-well chamber slide was used to perform the bacterial cell adhesion assay 
to DU-145 cells. A total of 0.5 ml of DU-145 cells (1.5 x 10
6
cells/ml) was seeded in each 
well. The chamber slide was incubated at 37°C overnight for attachment and fresh media 
was added. Fresh cultures of E. coli ORN178 (EC-178) and E. coli ORN208 (EC-208) 
were cultured overnight in Tryptic Soy Broth with ampicillin (50 µg/ml). The cultures 
were washed and resuspended in sterile PBS. A 100 µl (3 x 10
8
 cells/ml) aliquot of EC-
178 and 208 was added to two wells each in the chamber slide. The slide was incubated 
 90 
for 1, 2 and 3 h. At the 3 different time periods wells were washed with PBS and images 
were taken by a fluorescent scope (Zeiss LSM-510).  
 
DU-145 Cell growth curve 
Cells were plated 96-well microtiter plates at initial densities of 1000, 2000, 4000 
and 8000 cells per well. The cell culture medium was changed every 3 days. Cell growth 
was tested by the CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS) 
purchased from Promega, USA. It is a colorimetric method for determining the 
percentage of viable cells that are proliferating. Briefly, the MTS tetrazolium is 
bioreduced by the viable cells into a colored formazan product which is stable and can be 
measured at an absorbance of 490 nm. The amount of formazan produced is directly 
proportional to the number of living cells in the well. MTS assays were performed every 
day after seeding until day 8. All the experiments were carried out in triplicates.  
 
Cytotoxicity of GNPs to DU-145 cells 
The cytotoxicity of plain GNPs was tested by CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (MTS) purchased from Promega, USA. Cytotoxicity 
was measured in both the logarithmic and stationary phase of cell growth. For 
cytotoxicity measurements in the logarithmic phase, each cell line was incubated for 72 h 
in 96 well plate before adding the GNPs. Fresh medium containing increasing three 
different concentrations of the GNPs (10, 50 and 100 µl) was added to each well and the 
cells were incubated for 6, 24, 48 and 72 h time periods. The same was done for testing 
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cytotoxicity in the stationary phase. MTS assay was performed and the percentage of cell 
viability was determined.  
 
Cell uptake assay of plain and Mn-GNPs 
DU-145 cells (10 ml) were seeded in a cell culture dish containing 2 x 10
6
 cells 
and cultured overnight. Once the cells were 70% confluent they were treated with plain 
and mannose functionalized 20 and 200 nm GNPs (50 µl). After three hours of 
incubation, the unbound GNPs in the cell culture treatments were removed by washing 
the cells with PBS buffer twice. The cells were trypsinized with Trypsin-EDTA and 
centrifuged. After removal of the supernatant, the cells were resuspended in PBS to a 
final volume of 5 ml. At this stage the total number of cells was quantified with a 
hemocytometer. Five ml of 50% nitric acid (HNO3) was added to each sample to lyse the 
cells. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) was performed to 
measure the gold mass in the various samples. The number of GNPs was calculated via 
the gold mass. The total number of GNPs in the solution was divided by the number of 
cells to determine the number of GNPs taken up by the cells (Connor, Mwamuka et al. 
2005).  
 
Cytotoxicity of functionalized GNPs to DU-145 cells and E.coli ORN178 
The cytotoxicity of functionalized Mn-GNP of 200 nm particles was carried out 
by adding 200 µl of DU-145 cells (1.5 x 10
6
 cell per well) into a 96 well plate. After 
incubation at 37°C for 24 h, the cells were treated with 200 nm Mn-GNPs, 200 nm Mn-
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GNPs with bacteria EC-178 and 208. A total of volume 50µl of 200 nm Mn-GNPs was 
added. A preincubated mix, 1ml of the 200 nm Mn-GNPs and 1 ml of the 
microorganisms was incubated at 37°C with shaking for 1 h. The solution was 
centrifuged and washed with sterile PBS and resuspended in sterile PBS before adding to 
the 96 well plates. Different plates were set up for 6, 12, 24, 48 and 72 h time periods. 
The MTS assay was performed and the cell viability was determined.  
 
Protein corona of commercial 20 nm and 200 nm GNPs 
We wanted to study the protein adsorption of the commercial 20 nm and 200 nm 
GNPs to Fetal Bovine Serum (FBS) in DU-145 cell culture media and DMEM. The 20 
nm and 200 nm GNPs were incubated with DMEM and cell culture medium for 1 h at 
37°C. The 20 nm GNPs samples were spinned down at 10000 x g for 10 mins. The soups 
from FBS and DMEM samples were saved. The pellet containing the particles was 
washed thrice with nanopure water at 10000 x g. The particles were finally resuspended 
in nanopure water. The 200 nm GNPs were spinned down at 2655 x g for 10 mins.  
The soups from FBS and DMEM samples were saved. The pellet containing the 
particles was washed thrice with nanopure water at 2655 x g. The particles were finally 
resuspended in nanopure water. Samples of pure nanoparticles of both 20 and 200 nm 
GNPs, DMEM and cell culture medium were also included to compare the binding of the 
FBS proteins to the nanoparticle surface. SDS-PAGE was performed for all the samples 
using a 4-20% gel (Biorad, USA). The gel was stained by Coomassie blue stain. A Smart 
Protein standard (Genscript, USA) was used to identify and analyze the presence of BSA 
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bound to the samples. The gel bands were cut up and image taken accordingly. The 
hydrodynamic size of the plain GNPs and protein-bound GNP samples were measured 
using dynamic light scattering (DLS) using Malvern Zetasizer.  
 
Statistical analysis 
All experiments were carried out in triplicates with results expressed as mean 
±standard error (SE). Statistically significant differences were calculated using the two-
tailed unpaired t-test or one-way analysis of  ariance (ANOVA) with a p  alue of ≤0.05, 
p<0.01 and  p<0.001 considered significant using Prism 5.0 (GraphPad Software, CA). 
 
 
Results 
Binding of E. coli to DU-145 cells 
The binding of EC-178 and 208 to DU-145 was studied for 1, 2 and 3 h. Phase 
contrast images were taken as shown in Figure 4.1. It was seen that the EC-208 cells did 
not bind to DU-145 cells at all during all the three time periods which is expected as it 
serves as a negative control (Figure 4.1b). On the contrary the EC-178 cells bind to the 
DU-145 cells at 2 h time period (Figure 4.1d). After 3 h time period they were found to 
be associated with the DU-145 cells (Figure 4.1e). Due to the wash step after every time 
period it was seen that only few cells managed to bind to the DU-145 cells between 2-3 
hours. 
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DU-145 Cell growth curve 
In order to quantify the toxicity of the 20 nm and 200 nm GNPs in DU-145 cells a 
growth was carried out. Since cells that actively grow and divide during the logarithmic 
growth should be more vulnerable to toxic metallic particles than cells that are nearing or 
at the stationary phase of cell culture. Thus, the growth curve was determined to estimate 
the logarithmic and stationary growth phases in relation to the number of cells seeded 
into each well of a 96-well culture plate (Figure 4.2). It was observed that the cells reach 
the logarithmic phase by 3-4th day of incubation. By the eighth day the DU-145 cells are 
in stationary. 
 
Cytotoxicity of GNPs to DU-145 cells 
The cytotoxicity of 20 nm and 200 nm GNPs at the different time points in log 
phase is shown in Figure 4.3. It is seen that the 20 nm GNPs seem to have a significant 
effect on the DU-145 cells only after 48 and 72 h of incubation period in all the three 
concentrations. Not much difference in viability is observed by 200 nm GNPs in the log 
phase when compared to 20 nm GNPs. It is seen that the size did not cause much 
decrease or increase in cell viability. In case of the stationary phase (Figure 4.4), the 
cytotoxicity of 20 nm and 200 nm GNPs is significant as they show 24-31 % reduction in 
cell viability at mid-range of concentration (50 µl) compared to other low and high 
concentrations. Hence, it was observed that the mid-range of 50 µl volume of GNPs 
significantly affected the percent cell viability in both log and stationary phase.  
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Figure 4.1. a) DU-145 cells with EC-178 at 0 min, b) DU-145 cells with EC-208, c) DU-
145 cells with EC-178 at 1h, d) Bright field flourescent image of DU-145 cells with EC-
178 at 2h, e) DU-145 cells with EC-178 at 3h, f) Control DU-145 cells. 200X 
magnification. Scare bar – 10 um 
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Figure 4.2. Cell growth curve of DU-145 using different cell-plating numbers 
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Cell uptake assay of plain and Mn-GNPs 
After exposure to 20 and 200 nm plain and Mn-GNPs to DU-145 cells for three 
hours, the average number of GNPs per cell associated with each DU-145 cell was 
estimated as shown in Figure 4.5. The number of GNPs per cell in DU-145 cells was 3.4 
x 10
4
 for plain 20 nm GNP where as it was 1.7 x 10
4
 for 200 nm plain GNPs. In contrast, 
exposure to 20 nm Mn-GNPs results in as much twice the increase of nanoparticle uptake 
compared to the plain 20 nm plain GNPs. There was a significant increase in the uptake 
of the 200 nm Mn-GNPs, more than double the number of GNPs when compared to the 
plain 200 nm GNPs. There does not seem to be a significant difference between uptake 
levels of Mn-GNPs (both 20 and 200 nm).  
 
Cytotoxicity and competitive binding of functionalized  
GNPs to DU-145 cells and EC-178 
Figure 4.6 shows the cytotoxicity of functionalized GNPs to the DU-145 cells at 
1-6 h time points. A mid-range concentration of 200 nm Mn-GNPs (50 µl) was used in 
this assay. After various binding assays, it was seen that 50 µl is the minimum 
concentration 200 nm Mn-GNPs required to effect binding. It is seen that mannose 
functionalized 200 nm GNPs when bound to EC-178 relatively show the same percent 
viability when compared to the control DU-145 cells. On the other hand, the EC-178 
bacterial cells bring about cell death in about 6 h. When the 200 nm Mn-GNPs and 
EC178 are added together at once to the DU-145 cells, 64% viability of the cell line is 
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observed. But, when the 200 nm Mn-GNPs are premixed with EC-178 and then added to 
the DU-145 cell 73% viability is observed. 
This shows that when they are premixed the functionalized GNPs bind to EC-178 
and prevent the binding of the latter to DU-145, thereby increasing the cell viability. 
Even though the increase is not significant, it shows that there could be competitive 
binding between EC-178 and 200 nm Mn-GNPs to bind to DU-145 cells. This also 
suggests that the Mn-GNPs could competitively bind to the cell surface that has mannose 
residues and there by block the attachment of bacteria to those mannose residues on the 
cell surface receptors (Miura, Nishimura et al. 2001). 
 
Protein corona of GNPs 
The hydrodynamic sizes of the plain and protein coated GNPs did increase when 
incubated with FBS (Figure 4.7). The DLS measurements indicate that the protein in FBS 
did adsorb and hence the increase in diameter (Table 4.1).  
The 20 nm GNPs were found to be of 66.61±2.3 nm size and the 200 nm showed 
increase in size were of 261.9±5.3 nm.  This confirms the presence of protein corona 
which remained coated even after multiple washes. The zeta values do show good stable 
protein coated 20 and 200 nm GNPs. The SDS-PAGE gel was done to confirm the same 
(Figure 4.8). The 20 nm and 200 nm GNPs (arrow marks) do confirm the presence of 
protein corona with a clear thick band. The samples incubated with plain DMEM did not 
show any bands at all. Hence, it is clear that there was protein bound to the GNPs.  
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Figure 4.3. Cell cytotoxicity profiles of DU-145 cells in log phase. a) Cell viability of 
DU-145 in log phase when treated with plain 20 nm GNPs and b) Cell viability of DU-
145 in log phase when treated with 200 nm GNPs. *p<0.05, ***p<0.001 
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Figure 4.4 Cell cytotoxicity profiles of DU-145 cells in lag phase. a) Cell viability of DU-
145 in lag phase when treated with plain 20 nm GNPs and b) Cell viability of DU-145 in 
lag phase when treated with 200 nm GNPs **p<0.01, ***p<0.001 
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Figure 4.5. DU-145 cell uptake of plain GNPs (P-GNP) and mannose functionalized        
GNPs (Mn-GNPs) ***p<0.001 
 
 
 
 
 
 
 
*** 
 102 
 
 
 
 
 
 
 
Figure 4.6. DU-145 cell growth pattern with different treatments at 6, 12, 24, 48  and 72 h 
time points 
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Figure 4.7. Hydrodynamic size distribution of a) protein coated 20 nm GNP and b) 
protein coated 200 nm GNP 
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          Table 4.1. Hydrodynamic size distribution of GNPs 
Sample  Size (nm) Zeta potential 
(mV) 
20 nm GNP 24±2.1 -54.4 
Protein coated 20 nm GNP 66.61±2.3 -18.2 
200 nm GNP 213.5±2.9 -49.3 
Protein coated 200 nm GNP 261.9±5.3 -13.3 
 
 
 
 
 
 
Figure 4.8. Coomassie-stained SDS-PAGE gel lanes for protein coated 20 and 200 nm 
GNPs. FBS is a combination of  arious proteins. The lanes ’20 nm serum and 200 nm 
serum’ show a band for protein bound to the GNPs suggesting the presence of protein 
corona. The samples incubated with plain DMEM did not show any protein bands (data 
not shown) 
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Application of chemotherapy with GNPs is a new treatment approach in cancer 
therapy (Lehmann, Natarajan et al. 2008). There has been extensive research done and 
many underlying reasons have been identified for the invasiveness of prostate cancer. 
Cell-cell adhesion molecules that are involved in cell aggregation are calcium-dependent 
moieties known as cadherins. When there is a dysfunction in the cadherin pathway cancer 
tumor tends to become invasive. E-cadherin is a marker of carcinogenesis in prostate 
cancer. The cadherin family proteins have mannose residues on their cell surface 
receptors (Paul, Ewing et al. 1997). These mannose residues also are detected by the 
uropathogenic bacteria E. coli. Keeping this in mind, the 200 nm GNPs were only 
functionalized with mannose to test adhesion and cytotoxicity. The bigger size GNPs 
were used to functionalize with mannose than 20 nm GNPs because due to their increased 
size. If they bind to the DU-145 cells and competitively block the mannose residues from 
becoming available for uropathogenic bacteria. Also, if the Mn-GNPs do bind to the 
prostate cancer cells, then the uropathogenic bacteria can detect, chemotactically and 
specifically adhere to the mannose bound to GNPs.  
Once, many bacteria are bound to the GNPs then, due to their bigger size and the 
peristaltic flow near the tissue, the GNP-bacterial complex could be dislodged and can be 
detached from the prostate cancer cells. If this happens then the severity of the UTI can 
also be diagnosed, treated and prevented. As it was seen that the DU-145 cells are 
actively reproducing in log phase by 48 h of incubation, the cytotoxicity profiles 
indicated that there is no significant toxicity at all in 6 and 24 h incubated periods. Hence, 
Mn-GNPs can be safely used for detection or treatment of prostate cancer or UTI. The 
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viability profiles of DU-145 cells also indicate that the plain and Mn-GNPs do 
significantly decrease the viable cells by 48-72 h of incubation. Hence, if Mn-GNPs are 
used as a drug carrier can bring about synergistic killing of the prostate cancer and such a 
treatment is could be localized treatment and site directed when introduced locally. 
Compared to the 20 nm plain and Mn-GNPs were taken up by the DU-145 cells 
more than the 200 nm plain and Mn-GNPs. It has been documented that 15 nm glucose 
functionalized GNPs have been taken up more than the plain or chemically functionalized 
GNPs (Zhang, Xing et al. 2008). They have also demonstrated there is enhanced 
radiation sensitivity in prostate cancer by GNPs. Hence, if GNPs are functionalized with 
mannose sugar, they can be used as a vehicle to treat UTI. Gold nanoparticles are heavy 
metals with increased f-factor that enhance radiosensitivity have been studied in mice 
(Hainfeld, Slatkin et al. 2004; Wilson, Xiaojing et al. 2009). They attributed the 
sensitivity to the high-Z radio-enhancement by GNPs. Since the uptake studies of GNPs 
in this study indicate that 20 nm Mn-GNPs are taken up more than 200 nm Mn-GNPs, 
they could be used for killing the DU-145 cells in promising clinical applications if used 
as drug carrier. The 200 nm Mn-GNPs can be used for antiadhesion of uropathogenic 
bacteria in prostate cancer cells. This approach can be used for future treatment of UTI 
cases as there is an increase in antibiotic resistance of microorganisms.  
For this the uptake of the GNPs and their interaction with cellular proteins is 
essential. Hence, the protein adsorption of FBS on the 20 and 200 nm GNPs was studied. 
The DLS measurements and the SDS-PAGE gel indicate a strong band confirming the 
presence of the protein corona around the GNPs. It is crucial to know how the 
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nanoparticles behave in blood plasma and in vivo in general. Hence, there have been 
many studies where the GNPs have been studied in depth to understand the protein-
nanoparticle complexes in vitro to make the nanoparticles more robust and practical for 
various clinical applications. The chemical functionalization, size of the nanoparticle, 
type of proteins and surface charges do decide the biological fate of the nanoparticle 
when administered for therapeutic purposes (Pan, Neuss et al. 2007; Nativo, Prior et al. 
2008; Arnida, Malugin et al. 2010).  
This protein corona is important as it decides the particle’s longe ity in the blood 
stream which is very important for therapeutic efficacy. It has been shown that 30 and 50 
nm citrate-stabilized gold colloids were bound to 69 different proteins in plasma 
(Dobrovolskaia, Patri et al. 2009). It has been also demonstrated that the kinetic and 
equilibrium binding properties depend on protein identity as well as particle surface 
characteristics and size (Cedervall, Lynch et al. 2007). In order to understand the 
transport pathways utilized by nanoparticles, it is necessary to know how long lived they 
are in the living system, which will determine its biological fate (Lundqvist, Stigler et al. 
2011). Researches have demonstrated that 15 nm GNPs form proteins/NP complexes in 
RPMI are more abundantly internalized in cells as compared to DMEM, overall exerting 
higher cytotoxic effects in HeLa cells (Maiorano, Sabella et al. 2010). It is important to 
understand what happens to the fate of the nanoparticles once they have been utilized for 
biological applications.  
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In conclusion It has been shown previously in our previous investigation that 
GNPs when functionalized with D-mannose bind specifically to only EC-178 (Vedantam, 
Tzeng et al. 2012). Based on this fact our investigation attempted to carry out 
cytotoxicity assays with plain and Mn-GNPs it is seen that 20 and 200 nm GNPs bring 
out significant decrease in cell viability by 48-72 h only both in log as well as lag phase 
of DU-145 cells. Also, it has been shown that there might be a competitive binding 
between Mn-functionalized and GNPs when present together with DU-145 cells. The 
plain 20 nm GNPs were more inside the cell when compared to the plain 200 nm GNPs. 
The Mn-GNPs of 20 nm size were also taken up more compared to the 200 nm Mn-
GNPs.  
It was also demonstrated that both 20 and 200 nm GNPs do bind to protein and 
form a stable protein corona. Since it has been shown that GNPs of different sizes 
between 20-100 nm have shown to alter signaling pathways in cells and mediate 
biological processes (Jiang, KimBetty et al. 2008), based on which they can be used for 
targeted drug delivery as well as for detection purposes. Lastly, the binding of EC-178 
shows that competitive binding to Mn-GNP can be done to avoid binding of the bacteria 
to the DU-145 cells and hence, this mechanism can be further developed to prevent/detect 
recurrent UTI in prostate cancer cells.  
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CHAPTER FIVE 
BINDING OF ESCHERICHIA COLI TO FUNCTIONALIZED GOLD 
NANOPARTICLES 
 
 Introduction 
Tools for the study of bimolecular interactions have been developed based on the 
surface plasmon resonance of functionalized nanoparticles. Surface functionalization has 
proved to impart biofunctionality and this property has been exploited in developing 
different kinds of biosensors (Wijaya, Lenaerts et al. 2011). Although the application of 
colloidal metal nanoparticles in biology is not new, the optical observation of single 
metal particle labels and aggregated nanoparticles is of interest as a component of 
ultrasensitive detection systems. The surface plasmon resonance (SPR) is indicative of 
the light scattering by nanometer-sized colloidal metal particles. The function of the size, 
shape, particle properties can be inferred from the color of the light scattered. Colloidal 
gold nanoparticles (Au NPs) are brilliant red in color. Hence, biosensors, identification 
and detection systems of biomolecues can be developed based on the shift in SPR (David 
A 2003). Haynes et al. developed a biosensor that works by measuring a shift in the 
plasmon resonance peak induced by the local dielectric environment (Haynes and Van 
Duyne 2001).  
Haes et al. measured a shift in the PR peak caused by a change in the local 
dielectric environment in silver nanoparticle arrays that could function as sensitive and 
selective nanoscale affinity biosensors (Haes and Van Duyne 2002).   
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Colloidal Au NPs tend to settled down after few hours. By adjusting the distance 
between discrete nanoparticles or layers of nanoparticles, the SPR can be controlled 
(Schmitt, Decher et al. 1997). The peak of extinction will reduce, as the aggregate size 
increases shifting and broadenign the red plasmon band. Storhoff et al. have reported that 
extinction spectra for DNA-linked gold nanoparticle aggregates composed of equal 
number of particles but with smaller separations between particles and have red shift in 
the plasmon peak without causing significant loss in peak extinction (Storhoff, Lazarides 
et al. 2000).  
The optical response of a particular nanoparticle depends on its size and shape 
that defines the intrinsic modes as well as the dielectric environment that typically define 
the energy shifts. Taking advantage of the optical and electronic properties, Au NPs have 
been used in bioassays such as detection of DNA hybridization, probing binding to 
citrate-coated GNPs (Aizpurua, Hanarp et al. 2003; Brewer, Glomm et al. 2005). 
Another application of biodetection is use of nanoparticles extensively in 
pathogen detection (Jain 2005; Rosi and Mirkin 2005). Pathogens bind to eukaryotic cell 
membranes by crucial interactions with biomolecules on the surface of the cells. There is 
a lot of evidence that the complex oligosaccharides in the glycocalyx are key players in 
controlling the normal and pathological processes (Varki 1993; Dwek 1996) in 
mammalian cells. Glyconanoparticles could hence mimic a cellular model with 
carbohydrate presented on the cell surface, which can be used as excellent tools in 
biomedicine and glycobiology studies. Firstly, their size is in range to many common 
biomolecules; secondly, carbohydrate-modified nanoparticles can mimic biomolecules; 
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thirdly, they provide glycocalyx-like surface properties and lastly, they have unique 
physical properties due to the quantum size effect (Murray, Kagan et al. 2000; López-
Cartes, Rojas et al. 2005).   
Many groups have functionalized Au NPs with mono-, di-, tri- or oligo-
saccharides (Lin, Yeh et al. 2003; Aslan, Lakowicz et al. 2004; Zhang, Geddes et al. 
2004; Svarovsky, Szekely et al. 2005; Takae, Akiyama et al. 2005) with applications in 
biosensing, drug delivery, vaccine development and in vivo cell imaging. For instance, 
our previous research has demonstrated that, galactosylated polymeric polystyrene 
nanoparticles have shown significant aggregation when incubated with E. coli (Qu, Gu et 
al. 2005). UV-vis extinction properties of DNA-linked nanoparticle aggregates have been 
determined (Lazarides and Schatz 1999) and it is seen that depending on the particle 
volume fraction the aggregate size increases, the surface plasmon absorption peak shifts 
to longer wavelengths throughout the UV-vis range. This suggests that the denser and 
larger the aggregates, broader the plasmon feature. The shift in the SPR can be 
manipulated in designing biosensors that involve pathogen detection systems.  
By the use of glycan coated GNPs, the attachment/detachment mechanism of 
potential pathogens to Au NPs could be assessed and the optical properties displayed by 
the colloidal Au NPs can be measured. The role of sugar functionalized 200 nm (GNPs) 
in determining primary and fine sugar specificity in E. coli ORN178 and E. coli 13762 
was investigated. E. coli ORN178, which is a wild-type that causes urinary tract 
infection. It has type 1 fimbrial protein that confers the unique quality of binding to D-
mannose only (Harris, Spears et al. 2001). E. coli ORN208 was used as a negative 
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control. It has abnormal type 1 pili that fail to bind to D-mannose (Krogfelt, Bergmans et 
al. 1990). The other one is E. coli ATCC 13762 which causes enterotoxigenic diarrhea. 
E. coli 13762 is known as a K99+ strain that expresses K99 antigen that enters the 
humans as a foodborne pathogen via meat products especially in contaminated porcine 
meat. It has S type fimbrial proteins and binds specifically to Neuαc(α2-3)-Gal-(β1-4)Glc  
(Sharon 2006). 
 
Materials and methods 
Strains and Plasmid 
The strains E. coli ORN178 and ORN208 were provided by Dr. Chu-Cheng Lin, 
Department of Zoology, National Taiwan Normal University, Taiwan. E. coli 13762 and 
yeast strain Saccharomyces cerevisiae were obtained from the American Type Culture 
Collection (ATCC) (Manassas, VA, USA). Transformed strains of E. coli ORN178 and 
ORN208 were procured from our lab. GFP-expressing bacterial cells of the three select 
strains were harvested from a TSA medium supplemented with ampicillin (50µg/ml). 
Yeast cells were cultivated at 30ºC on Potato Dextrose Agar (VWR, USA). 
 
Transformation of the bacteria 
Escherichia coli 13762 were transformed with plasmid pGREEN by 
electroporation (Sambrook and Russell 2001). The electro-competent cells were prepared 
by growing them in SOB medium (VWR, USA) with shaking at 37ºC to an optical 
density 0.6 (OD600). The cells were harvested and centrifuged. They were washed with 
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ice-cold wash buffer (10% v/v glycerol in water). The cells were then resuspended in 3 
ml of wash buffer and stored in eppendorf tubes containing100 µl quantity. 
Electrocompetent cells were stored in -80ºC. An aliquot of 100 µl competent cells was 
mixed with 100 ng of plasmid DNA of pGREEN. Transformation was carried out via 
electroporation using an ECM 399 Electroporation System (BTX, San Diego, CA) was 
achieved in a 0.1 cm gap cuvette at 1800 V, 50 µF, and 150 W. The mixture was pulsed 
and transferred to an eppendorf tube containing 1 ml of SOC (SOB plus 20 mM Mg
2+
 and 
20 mM glucose) recovery medium. After allowing the cells to recover for two hours the 
cells were plated on Tryptic soy agar (TSA) with Ampicillin (50 µg/ml). Antibiotic 
resistance was checked by exposing the bacterial cells to blue light (488 nm).  
 
Yeast Agglutination Assay 
Yeast binding assay was done in order to verify the mannose-binding 
characteristics of E. coli 13762 (Ofek I and R.J. Doyle 1994). It has been established that 
E. coli 13762 (K99) has receptors for galactose and not mannose moieties (Sharon and 
Ofek 2000). Hence, this assay will confirm the binding specificity of the K99 strain and 
make sure if the transformation altered the binding profile of the organism.  
 
Functionalization of GNP 
Colloidal Au NPs of 200 nm size of 7 x 10
8
 particles/ml  concentration were 
purchased from, Ted Pella Inc., (USA). The Neuαc(α2-3)-Gal-(β1-4)Glc–Paa (Sg) was 
procured from Glyco Tech Corporation (USA) and D-Mannan (Mn) was purchased from 
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VWR (USA). The sugars were dissolved in 0.3 M sodium phosphate buffer. Absolute 
ethanol, 2-(2-aminoethoxy)ethanol (AEE) and N-hydroxy-2,5-pyrrolidinedione (NHS), 
16-Mercaptohexadecanoic acid (16-MHDA), epichlorohydrin, 2-methoxyethyl ether 
(diglyme), N-3-(Dimethylaminopropyl)-N-ethyl-carbodiimide (EDC) were obtained from 
VWR (USA).  
Sodium phosphate monobasic buffer solution (10mM) concentration at pH 7 was 
used. PBS of pH 7.4 in deionized water was used. All buffers were prepared in deionized 
water (>18M/cm). Glassware was washed with “piranha solution” (3:7, 30% 
H2O2/H2SO4). Degassed ethanol was used to prepare 0.50mM 16-MHDA. 
 
Preparation of functionalized Au NPs 
 The surface modification of the gold colloids was carried out by a modified 
multistep procedure as represented in Figure 5.1(Aslan, Lakowicz et al. 2004). Tween 20 
was not used for physisorption as the nanoparticles’ surfaces were plain with no charges. 
Briefly, the Au NPs were degassed with Argon gas. Equal volumes (500 µl) of 200 nm 
Au NP dispersions and 0.50mM 16-MHDA was then added and the final mixture was 
allowed to stand for 3 h for the chemisorption of 16-MHDA to gold colloids. Excess 16-
MHDA was removed by centrifuging the mixture three times for 5 min at 1699 × g; the 
supernatants were discarded after each cycle and resuspended in phosphate buffer. 16-
MHDA-modified gold colloids that remained in the centrifugate were then reacted with a 
mixture of freshly prepared 50mM NHS and 200mM EDC solution for 5 min. The 
resulting nanoparticle dispersion was centrifuged at 5 min, 1699 × g. The supernatant was 
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discarded, the remaining NHS ester-alkane thiol-modified Au NPs were reacted with a 
freshly prepared solution of AEE (2%, v/v) for 10 min. Excess AEE was removed by 
centrifugation for 5 min at 1699 × g at least three times. The pellet that contained AEE-
modified Au NPs was centrifuged (5 min, 1699 × g). The hydroxyl groups on the AEE-
modified Au NPs were activated with 0.6M epicholorohydrin solution in a 1:1 mixture of 
0.4M NaOH and diglyme for 4 h at room temperature. The nanoparticle dispersion was 
then centrifuged for 10 min at 1699 × g and resuspended in diglyme and centrifuged 
again to remove the excess epicholorohydrin. The centrifugate, containing AEE-modified 
Au NPs now with active epoxide groups, were incubated in two glycan solutions namely, 
Sg and Mn solutions (0.1M NaOH) for 20 h. Finally, Sg and Mn-modified Au NPs were 
centrifuged for 5 min at 1699 × g and resuspended in 0.1M NaOH and centrifuged four 
more times to remove the excess sugar. The different sugar modified GNPs: Mn-Au NPs 
and Sg-Au NPs were stored in eppendorf tubes wrapped with aluminum foil in order to 
avoid aggregation induced by light.  
The UV-Vis measurement for four selected functionalized Au NP samples:  
pristine Au NP, MHDA-Au NP, AEE-Au NP and E. coli ORN178 bound to Mn-Au NPs 
was carried out using a LAMBDA 950 UV/Vis/NIR Spectrophotometer (Perkin-Elmer, 
USA). Hydrodynamic diameter (Dz) and size distributions for the four GNP samples in 
aqueous solutions were determined by dynamic light scattering (DLS). The DLS 
instrumentation consisted of Malvern Zetasizer Nano ZS (Worcestershire, U.K.) system, 
ZEN3600 model. Measurements of diameter and ζ potential were made at 25 ± 1 °C. The  
 
 118 
ζ a erage diameter reported herein was obtained as the a erage of three 
measurements performed on each sample. The morphology of the samples was imaged 
using a Hitachi S3400 scanning electron microscopy (SEM), model. A drop of the 
samples was put on poly-L-Lysine coated Si substrates, was air dried for 2 hrs and 
observed under SEM. 
 
Confocal Imaging of Bacterial Agglutination by Fluorescence Microscopy 
The E. coli ORN178, ORN 208 and K99 were grown on TSA plates containing 
ampicillin (50 µg/ml). Cells were washed with PBS and standardized to a concentration 
of 3 x 10
5
 cells/ml. GNP suspension (3.5% wt/wt) was mixed with an equal volume of 
bacterial cell suspensions in eppendorf tubes. The mixture was inverted gently for few 
times and incubated for 15 minutes at room temperature on an orbital shaker with mild 
rotation. Wet mounts of the different samples were made and degree of aggregation was 
qualitatively assessed under a fluorescence microscope (Zeiss LSM-510). Different 
controls were set up for the three different types of E. coli. Negative control consisting of 
the particles only was also set up.  
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Figure 5.1. Scheme of functionali ation of Mn and Sg coated 200 nm Au NPs (Aslan, 
La owic  et al. 2004) 
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Results 
Transformation of the E. coli K99 strain 
The E. coli 13762 were successfully transformed (Figure 5.2). The transformants 
fluoresced when viewed under the fluorescence microscope (Zeiss LSM-510) under the 
green fluorescent protein (GFP) filter. E. coli ORN178 (Figure 5.2a) and ORN208 
(Figure 5.2b) appeared to be considerably longer rods when compared to the short rods of 
E. coli 13762 (Figure 5.2c).   
 
Yeast agglutination Assay 
The mannose binding characteristics of the transformants were verified using a 
yeast agglutination assay (Ofek, Mirelman et al. 1977) to document that the 
transformation had not altered the previously determined mannose-binding characteristics 
of E. coli ORN178 and ORN208. The binding specificity of E. coli 13762 to mannose 
was also determined. Figure 5.3a shows the transformant E. coli ORN178, not the 
ORN208 (Figure 5.3b), mediated the agglutination of yeast cells. Both strains were found 
to retain the same characteristics as their parent strains regarding their mannose-binding 
activities.  E. coli 13762 (Figure 5.3c) did not show any visible binding to yeast cells both 
in the fluorescent and brightfield images indicating that they lack type 1 binding fimbria.  
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Figure 5.2. Fluorescent images of transformed a E. coli ORN178, b E. coli ORN208, and 
c E. coli 13762 with pGREEN plasmid as seen at 400× magnification. Scale bar 10 μm 
 
 
 
 
Figure 5.3. Yeast agglutination assay. a E. coli ORN178 binds to yeast cells and bring 
about clumping (400×), b no binding is seen in case of E. coli ORN208 (400×), and c 
shows no binding of E. coli 13762 with yeast cells. Scale bar 10 μm  
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Characterization of functionalized GNPs 
The functionalized GNPs were characterized by UV-visible absorption 
spectroscopy, dynamic light scattering (DLS) and scanning electron microscopy (SEM) 
on pristine, MHDA, AEE- Au NPs and binding of E.coli ORN178 to Mn functionalized 
Au NPs. The SPR absorbance was found to be similar in the case of Sg-GNPs bound to 
E. coli 13762; hence, only the absorbance of Mn-Au NPs was studied. The plasmon band 
observed for the pristine Au NPs was at 570 nm which is characteristic of 200 nm GNPs 
(Figure 5.4). 
The initial characterization of MHDA and AEE-GNPs also showed absorption 
maximum (max) of the surface plasmon band at 570 nm indicating the presence of 
functionalized GNPs in the functionalized samples. The Mn-GNPs when bound to E. coli 
ORN178 also displayed a SPR band of 570 nm. It is clearly seen that Au NPs keep their 
nano form even after chemical modifications. Although MHDA-Au NPs and AEE-Au 
NPs do aggregate as seen in Figure 5.5b and 5.5c, their size remains the same according 
to the DLS data obtained (Table 5.1). Figure 5.5d shows the binding of E.coli ORN178 to 
the Mn-Au NPs.  
The pristine Au NPs as seen in the SEM image (Figure 5.5a) remain suspended, 
but the other samples do aggregate. The diameters of the samples measured in dispersion 
are listed in Table 5.1. The DLS data shows that that the mean diameter of pristine Au 
NPs is 213.5 nm. The diameter range of the pristine Au NPs is slightly larger than the 
quoted by the manufacturer (200 nm). This is not unexpected, as the DLS system is 
measuring the hydrodynamic size of the hydrated particles. The mean size of the MHDA-
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Au NP, AEE-Au NP and E.coli ORN178 bound to Mn-Au NPs increase due to 
aggregation. All the four samples indicated a negati e charge as determined by ζ 
potential measurements. The ζ-potential of the four samples ranged from -49.3 mV to -
9.82 mV as the si e of the sample increases. Mean ζ potential  alue of pristine Au NP 
colloids has been reported to be -42.5 (Diegoli, Manciulea et al. 2008), the values listed 
in Table 5.1 are consistent.  As the Au NPs get functionalized they tend to aggregate and 
hence, could tend to be more unstable as a result of aggregation. This could cause the 
drop in ζ potential -49.3 mV of pristine Au NPs to -9.82 mV of the Mn-Au NPs bound to 
E. coli ORN178.  
 
Binding of E. coli to GNPs 
Binding specificities were examined as depicted in Figure 5.6. After incubation of 
Mn-GNPs with the E. coli ORN178 cells formed bacterial clumps, which emitted a bright 
fluorescence signal. These bacterial clumps consisted of hundreds of aggregated bacterial 
cells. The Mn-GNPs were found to aggregate in the presence of E. coli ORN178 only. 
Binding was in accordance to the yeast agglutination assay results showing that E. coli 
ORN178 has specific binding to mannan (Figure 5.6b&c). E. coli 13762 did not show 
any binding to Mn-GNPs, but consistently binds specifically to Sg-GNPs (Figure 
5.6e&f). Bacterial clumps were formed by agglutination of Sg-GNPs and E. coli 13762 
(Figure 5.6g&h). This proves that the two different E. coli have different binding 
specificities. The E. coli ORN178 did not show binding to Sg-GNPs. Specific binding of 
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Mn-GNPs to E. coli ORN178 and binding of Sg-GNPs to E. coli 13762 have been 
demonstrated.   
This phenomenon is not a result of adsorption because no binding has been 
observed with bare GNPs lacking the Mannan or the Sg moieties (Figure 5.6a). E. coli 
ORN208 was used as a negative control in our experiments. It was not surprising that the 
abnormal type 1 pili expressing ORN208 clearly exhibited no binding to GNPs, Mn-
GNPs or Sg-GNPs. 
An example of non-attachment of E. coli ORN208 with Mn-GNPs (Figure 5.6d) 
is presented to show no binding. Samples at various stages of functionalization were kept 
aside to test binding of all the three bacterial strains. The intention was to see if any of the 
16-MHDA/NHS/AEE/ECH-modified-GNPs could mediate aggregation by the means of 
surface absorption. Except for the sugar-modified-GNPs, no binding occurred during the 
course of the multi-step reaction.   
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Figure 5.4. UV–vis absorbance of plain, 16-MHDA modified Au NP and Mn–Au NPs 
bound to E. coli ORN178 
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Table 5.1. DLS mean diameters and zeta potentials of functionalized Au NPs 
Sample z (mV) Mean size (nm) 
Pristine GNPs -49.3 213.5 
MHDA-GNPs -36.6 226.4 
AEE-GNPs -14.0 462.7 
Mn-GNPs -9.82 5076 
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Figure 5.5. SEM images of a pristine Au NPs, b MHDA Au NPs, c AEE–Au NPs, and d 
aggregate of Mn–Au NPs and E. coli ORN178 
 
 
 
 
 128 
Discussion 
The optical spectrum of colloidal gold suspensions is dominated by SPR band, 
which is due to the collective dipole oscillation in the conduction band of gold. The 
position, intensity and the shape of the plasmon resonance band is influenced by many 
factors such as particle size and shape, dispersity and degree of aggregation (Diegoli, 
Manciulea et al. 2008). Dielectric constant and other stabilizing agents play an important 
role in conduction of Au band (David A 2003). The longitudinal plasmon resonance band 
has also been found indicative of Au NPs coming in close proximity during aggregation.   
Diegoli et al. have also shown that the most there is a distinctive region in the 
plots of ζ-potential  ersus particle concentration, in which the ζ potential  alue is 
independent of nanoparticle concentration (Diegoli, Manciulea et al. 2008). It is referred 
to as the “stable region” of the plot. The results showed sample stability was indicated by 
their large negati e ζ potential values, with the average mean ranging from -43 to -56 
mV. Moreover, DLS and SEM results in this study have corroborated the results obtained 
by UV-visible spectroscopy. 
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Thus by exploiting the sensitivity of the optical parameters of particles, Au NPs 
can be used as a novel tool for pathogen detection which in this case is based on 
microbiological aspect of the E. coli strains binding to different sugars is simply based on 
their structural characteristics.  
The most important life style of E. coli is its mechanism of attachment to host 
tissue. The myriad of adhesins discovered in E. coli to demonstrate the fact that it is an 
important determinant in establishment of bacterial attachment followed by colonization 
and infection. Pathogenic E. coli expresses many different kinds of adhesins which can 
be grouped according to their affinity to specific receptor structures. The functional 
organization of fimbrial lectin is different with respect to the position of the receptor 
binding sites. Primary sugar specificity or the fine sugar specificity by and large defines 
the specificity of the fimbrial lectin. The former refers to a simple carbohydrate structure, 
for example a monosaccharide that can inhibit the lectin mediated adhesion; whereas the 
latter refers to differences in binding to different oligosaccharides in lectins 
demonstrating the same primary sugar specificity (Sharon and Ofek 2000). Many 
enterobacteria express D-mannose lectins, which conform to the primary sugar specificity 
for type 1 fimbriae. Enterobacterial fimbrail adhesins that have been characterized 
according to their sugar specificities (Sharon and Ofek 2000). They are α-D-mannosides 
(type 1 fimbrial adhesin), α-D-Gal-(1-4)-β-D-Gal (P fimbrial adhesin) and NeuAcα2,3-
galactose (S fimbrial adhesin) (Sokurenko, Chesnokova et al. 1997; Lin, Yeh et al. 2002). 
The type 1 fimbria of E. coli ORN178 consists of mannose binding FimH lectin 
that aids in binding to glycoproteins that are a part of the adhesive domain on host cells. 
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The globoside-binding P fimbria of uropathogenic E. coli has shown to bind to the 
urolapkins on the surface of urothelial cells of the human bladder (Wu, Sun et al. 1996; 
Westerlund-Wikström and Korhonen 2005). Not only the type 1 fimbrial proteins have 
demonstrated a vital role in colonization of E. coli on host intestinal surfaces, they also 
play a role in causing urinary tract infections (Hung, Bouckaert et al. 2002). The 
enterotoxigenic (ETEC) E. coli (K99) causes diarrhea in animals such as pigs, calves and 
lambs (Simons, Willemsen et al. 1990).  
A ganglioside glycolipid in FanC is involved in fimbrial adhesion, which consists 
of tetrasaccharide GalNAcβ-3Galα1-4Galβ1-4Glc in the binding pocket of K99. This 
ceramide when involved in lectin-binding pocket interaction brings about considerable 
conformational change in the binding protein that causes adhesion to host cells (Simons, 
Willemsen et al. 1991). Based on these factors two different types of E. coli strains were 
selected in order to study their binding specificity and from Figure 5.6 we can clearly 
concur that the primary and fine sugar specificities do play an important role in 
pathogenesis.  
The yeast agglutination assay clearly indicated primary specificity by type 1 
mediated binding of E. coli ORN178 to mannan residues on the surface of yeast cells. On 
the contrary, fine sugar specificity brought about no agglutination in E. coli 13762 (aka 
E. coli K99) with yeast cells as it exhibits type S fimbrial adhesins. It recognizes only a 
specific oligosaccharide sequence, i.e., NeuAc(α2-3)Gal(β1-4), which is not a part of 
yeast cell surface receptors. Due to the presence of abnormal pili, E. coli ORN208 failed 
to bind to yeast cells. A detailed study where mannose GNPs have been used to observe 
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the specific binding to FimH adhesion of bacterial type 1 pili by TEM has been 
demonstrated (Lin, Yeh et al. 2002). This establishes that aggregation of E. coli ORN178 
was induced specifically by mannan recognition on the surface of the yeast cells.  
In conclusion the UV-Vis measurements indicate the presence of Au SPR band 
confirming the nanoform of the particles despite functionalizing them. The mean sizes of 
the four select samples increased due to aggregation. The ζ potential dropped as the 
particles changed from a suspended to an aggregated state. We also found that mannose 
functionalized Au NPs (Mn-GNPs) specifically bind with E. coli ORN178 only but not 
with E. coli 13762. Fine sugar specificity was obser ed when Neuαc(α2-3)-Gal-(β1-
4)Glc –Paa functionalized GNPs (Sg-GNPs) specifically showed binding with E. coli 
13762 but not with E. coli ORN178. These results indicate that the binding induced by 
sugar-modified GNPs is specific to the characteristic sugar that bacteria recognize on 
binding sites located around the cell surface and, that such glyconanoparticles have the 
potential use in the identification of pathogens and also competitively prevent the binding 
of microorganisms to the eukaryotic cell surface receptors. 
Biofunctionalized nanoparticles can serve as excellent carrier systems. With 
multiple receptors immobilized on carrier surface, each particle could interact with 
multiple bacteria resulting in the formation of aggregates. Merging of multiple aggregates 
mediated by these carrier particles could further prevent the bacteria from attaching to the 
host cells, especially in the urinary and the intestinal tracts owing to the high peristaltic 
pressures. The in vivo effects of the surface chemistry of the functionalized nanoparticles 
and their behavior in the UTI/intestinal tract warrant further investigation.  
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It is seen that UTI causing E. coli ORN178 evidently binds only to Mn-GNPs and 
not to Sn-GNPs. And ETEC 13762 exhibited specificity in binding to only Sn-GNPs and 
not to mannan. This indicates that there is high specificity in adhesin mediated binding 
exhibited by different microorganisms. From the above discussion it is clear that type 1 
specificity is exhibited by many microorganisms that can easily bind to D-mannose and 
mediate generic adhesion, whereas certain microorganisms also recognize specific 
carbohydrate sequence which defines their fine sugar specificity. In the latter case, there 
is adhesin-specific adhesion that is not generic in nature. This means that binding of 
microorganisms can be altered with the use of carbohydrate functionalized nanoparticles 
to competitively bind to the cell surface receptors and block the adhesion of pathogens.  
Theoretically, it can be envisioned that in such a scenario, binding can be reversed 
by aggregation of large amounts of functionalized GNPs clumping together and 
detaching the bacteria from the cell surface. Such nanoparticles could lead to the 
development of diagnostic tools that not only identify generic binding but also, can detect 
presence of specific species in a given genus. With the fast emerging antibiotic/drug 
resistant strains, nanoparticles may be employed to reduce the microbial load in 
diagnosis/treatment of medical diseases, contamination of food products, treatment of 
meat and poultry products, as carriers to deliver a particular drug for a localized effect, 
bioimaging of tissues and lastly as models for repairing cellular functions and alter 
pathogenesis.  Our results there by indicate that blockage of bacterium-host interaction by 
specific sugar-modified GNPs can be an effective method for removal of bacteria from 
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hosts and detection of specific optical properties of the nanoparticles used can further 
assess the extent of binding.   
 
Literature Cited 
Aizpurua, J., Hanarp, P., Sutherland, D. S., Käll, M., Bryant, G. W., & García de Abajo, 
F. J. (2003). Optical Properties of Gold Nanorings. Physical Review Letters, 
90(5), 057401.  
Aslan, K., Lakowicz, J. R., & Geddes, C. D. (2004). Nanogold-plasmon-resonance-based 
glucose sensing. Anal Biochem, 330(1), 145-155. doi: 10.1016/j.ab.2004.03.032 
            S0003269704002647 [pii] 
Aslan, K., Lakowicz, J. R., & Geddes, C. D. (2004). Tunable plasmonic glucose sensing 
based on the dissociation of Con A-aggregated dextran-coated gold colloids. 
Analytica Chimica Acta, 517(1–2), 139-144. doi: 
http://dx.doi.org/10.1016/j.aca.2004.04.060 
Brewer, S. H., Glomm, W. R., Johnson, M. C., Knag, M. K., & Franzen, S. (2005). 
Probing BSA Binding to Citrate-Coated Gold Nanoparticles and Surfaces. [doi: 
10.1021/la050588t]. Langmuir, 21(20), 9303-9307. doi: 10.1021/la050588t 
David A, S. (2003). Plasmon resonant particles for biological detection. [doi: 
10.1016/S0958-1669(02)00015-0]. Current Opinion in Biotechnology, 14(1), 13-
22.  
Diegoli, S., Manciulea, A. L., Begum, S., Jones, I. P., Lead, J. R., & Preece, J. A. (2008). 
Interaction between manufactured gold nanoparticles and naturally occurring 
organic macromolecules. [doi: 10.1016/j.scitotenv.2008.04.023]. Science of The 
Total Environment, 402(1), 51-61.  
Dwek, R. A. (1996). Glycobiology: Toward Understanding the Function of Sugars. Chem 
Rev, 96(2), 683-720. doi: cr940283b [pii] 
Haes, A. J., & Van Duyne, R. P. (2002). A Nanoscale Optical Biosensor:  Sensiti ity and 
Selectivity of an Approach Based on the Localized Surface Plasmon Resonance 
Spectroscopy of Triangular Silver Nanoparticles. [doi: 10.1021/ja020393x]. 
Journal of the American Chemical Society, 124(35), 10596-10604. doi: 
10.1021/ja020393x 
Harris, S. L., Spears, P. A., Havell, E. A., Hamrick, T. S., Horton, J. R., & Orndorff, P. E. 
(2001). Characterization of Escherichia coli Type 1 Pilus Mutants with Altered 
Binding Specificities. J. Bacteriol., 183(13), 4099-4102. doi: 
10.1128/jb.183.13.4099-4102.2001 
Haynes, C. L., & Van Duyne, R. P. (2001). Nanosphere Lithography:  A Versatile 
Nanofabrication Tool for Studies of Size-Dependent Nanoparticle Optics. [doi: 
10.1021/jp010657m]. The Journal of Physical Chemistry B, 105(24), 5599-5611. 
doi: 10.1021/jp010657m 
 135 
Hung, C.-S., Bouckaert, J., Hung, D., Pinkner, J., Widberg, C., DeFusco, A., . . . 
Hultgren, S. J. (2002). Structural basis of tropism of Escherichia coli to the 
bladder during urinary tract infection. Molecular Microbiology, 44(4), 903-915. 
doi: 10.1046/j.1365-2958.2002.02915.x 
Jain, K. K. (2005). Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta, 
358(1-2), 37-54. doi: S0009-8981(05)00145-2 [pii] 10.1016/j.cccn.2005.03.014 
Krogfelt, K. A., Bergmans, H., & Klemm, P. (1990). Direct evidence that the FimH 
protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect. 
Immun., 58(6), 1995-1998.  
Lazarides, A. A., & Schatz, G. C. (1999). DNA-Lin ed Metal Nanosphere Materials:  
Structural Basis for the Optical Properties. [doi: 10.1021/jp992179+]. The Journal 
of Physical Chemistry B, 104(3), 460-467. doi: 10.1021/jp992179+ 
Lin, C. C., Yeh, Y. C., Yang, C. Y., Chen, C. L., Chen, G. F., Chen, C. C., & Wu, Y. C. 
(2002). Selective binding of mannose-encapsulated gold nanoparticles to type 1 
pili in Escherichia coli. J Am Chem Soc, 124(14), 3508-3509. doi: ja0200903 [pii] 
Lin, C. C., Yeh, Y. C., Yang, C. Y., Chen, G. F., Chen, Y. C., Wu, Y. C., & Chen, C. C. 
(2003). Quantitative analysis of multivalent interactions of carbohydrate-
encapsulated gold nanoparticles with concanavalin A. Chem Commun 
(Camb)(23), 2920-2921.  
López-Cartes, C., Rojas, T. C., Litrán, R., Martínez-Martínez, D., de la Fuente, J. M., 
Penadés, S., & Fernández, A. (2005). Gold Nanoparticles with Different Capping 
Systems:  An Electronic and Structural XAS Analysis. [doi: 10.1021/ p050184+]. 
The Journal of Physical Chemistry B, 109(18), 8761-8766. doi: 
10.1021/jp050184+ 
Murray, C. B., Kagan, C. R., & Bawendi, M. G. (2000). Synthesis and characterization  
            of Monodisperse Nanocrystals and close-packed Nanocrystal and assemblies.            
Annual Review of Materials Science, 30(1), 545-610 
doi:10.1146/annurev.matsci.30.1.545 
Ofek I, & R., D. (1994). Bacterial adhesion to cells and tissues: ondon: Chapman & Hall. 
Ofek, I., Mirelman, D., & Sharon, N. (1977). Adherence of Escherichia coli to human 
mucosal cells mediated by mannose receptors. Nature, 265(5595), 623-625.  
Qu, L., Gu, L., Li, H., Taylor, S., Elkin, T., Luo, P. G., . . . Sun, Y.-P. (2005). 
Galactosylated Polymeric Nanoparticles: Synthesis and Adhesion Interactions 
with Escherichia coli. [doi:10.1166/jbn.2005.009]. Journal of Biomedical 
Nanotechnology, 1, 61-67.  
Rosi, N. L., & Mirkin, C. A. (2005). Nanostructures in biodiagnostics. Chem Rev, 105(4), 
1547-1562. doi: 10.1021/cr030067f 
Sambrook, J., & Russell, D. (2001). Molecular Cloning: A Laboratory Manual: Cold 
Spring Harbor Laboratory Press. 
Schmitt, J., Decher, G., Dressick, W. J., Brandow, S. L., Geer, R. E., Shashidhar, R., & 
Calvert, J. M. (1997). Meta 
l nanoparticle/polymer superlattice films: Fabrication and control of layer structure. 
Advanced Materials, 9(1), 61-65. doi: 10.1002/adma.19970090114 
 136 
Sharon, N. (2006). Carbohydrates as future anti-adhesion drugs for infectious diseases. 
[doi: DOI: 10.1016/j.bbagen.2005.12.008]. Biochimica et Biophysica Acta (BBA) 
- General Subjects, 1760(4), 527-537.  
Sharon, N., & Ofek, I. (2000). Safe as mother's milk: Carbohydrates as future anti-
adhesion drugs for bacterial diseases. Glycoconjugate Journal, 17(7), 659-664. 
doi: 10.1023/a:1011091029973 
Simons, B. L., Willemsen, P. T. J., Bakker, D., Roosendaal, B., De Graaf, F. K., & 
Oudega, B. (1990). Structure, localization and function of FanF, a minor 
component of K99 fibrillae of enterotoxigenic Escherichia coii. Molecular 
Microbiology, 4(12), 2041-2050. doi: 10.1111/j.1365-2958.1990.tb00564.x 
Simons, L. H., Willemsen, P. T. J., Bakker, D., de Graaf, F. K., & Oudega, B. (1991). 
Localization and function of FanH and FanG, minor components of K99 fimbriae 
of enterotoxigenic Escherichia coli. [doi: DOI: 10.1016/0882-4010(91)90018-6]. 
Microbial Pathogenesis, 11(5), 325-336.  
Sokurenko, E. V., Chesnokova, V., Doyle, R. J., & Hasty, D. L. (1997). Diversity of the 
Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and 
uroepithelial cells. [Research Support, Non-U S Gov't 
Storhoff, J. J., Lazarides, A. A., Mucic, R. C., Mirkin, C. A., Letsinger, R. L., & Schatz, 
G. C. (2000). What Controls the Optical Properties of DNA-Linked Gold 
Nanoparticle Assemblies? [doi: 10.1021/ja993825l]. Journal of the American 
Chemical Society, 122(19), 4640-4650. doi: 10.1021/ja993825l 
Svarovsky, S. A., Szekely, Z., & Barchi, J. J. (2005). Synthesis of gold nanoparticles 
bearing the Thomsen-Friedenreich disaccharide: a new multivalent presentation of 
an important tumor antigen. [doi: DOI: 10.1016/j.tetasy.2004.12.003]. 
Tetrahedron: Asymmetry, 16(2), 587-598.  
Takae, S., Akiyama, Y., Otsuka, H., Nakamura, T., Nagasaki, Y., & Kataoka, K. (2005). 
Ligand Density Effect on Biorecognition by PEGylated Gold Nanoparticles:  
Regulated Interaction of RCA120 Lectin with Lactose Installed to the Distal End 
of Tethered PEG Strands on Gold Surface. [doi: 10.1021/bm049427e]. 
Biomacromolecules, 6(2), 818-824. doi: 10.1021/bm049427e 
Varki, A. (1993). Biological roles of oligosaccharides: all of the theories are correct. 
Glycobiology, 3, 1297 - 1340.  
Westerlund-Wikström, B., & Korhonen, T. K. (2005). Molecular structure of adhesin 
domains in Escherichia coli fimbriae. [doi: DOI: 10.1016/j.ijmm.2005.06.010]. 
International Journal of Medical Microbiology, 295(6-7), 479-486.  
Wijaya, E., Lenaerts, C., Maricot, S., Hastanin, J., Habraken, S., Vilcot, J.-P., . . . 
Szunerits, S. (2011). Surface plasmon resonance-based biosensors: From the 
development of different SPR structures to novel surface functionalization 
strategies. [doi: 10.1016/j.cossms.2011.05.001]. Current Opinion in Solid State 
and Materials Science, 15(5), 208-224.  
Wu, X. R., Sun, T. T., & Medina, J. J. (1996). In vitro binding of type 1-fimbriated 
Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. 
Proceedings of the National Academy of Sciences of the United States of America, 
93(18), 9630-9635.  
 137 
Zhang, J., Geddes, C. D., & Lakowicz, J. R. (2004). Complexation of polysaccharide and 
monosaccharide with thiolate boronic acid capped on silver nanoparticle. [doi: 
DOI: 10.1016/j.ab.2004.05.051]. Analytical Biochemistry, 332(2), 253-260.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 138 
CHAPTER SIX 
 
 
CONCLUSION 
 
Various strategies have been employed in synthesis of nanoparticles in order to 
ma e them biocompatible. Based on the type of synthesis the nanoparticle’s beha ior in 
vitro varies. The initial studies of this dissertation focused on the cytotoxicity profiles of 
commercial, laser ablation and green synthetic particles. Extend of DNA damage caused 
in term of apoptosis indicated that not only apoptosis was size dependent but was also 
significantly different when compared to the commercial and laser ablation nanoparticles. 
Due to their chemically active surface charges the laser ablation particles show potential 
use in cancer therapy. Whereas there is also a great thrust in the green nanotechnology for 
development of cost effective methods of production of good quality nanostructures with 
practical commercial viability. But due the fact that green synthesis method leads to the 
formation of mono and poly-disperse nanoparticles, the stability and size control of the 
nanoparticles needs to be further investigated in order to the used as functional 
nanoparticles for biomedical applications.  
The gold and silver nanoparticles used in this study showed promising in 
antibacterial properties due the partial influence of the properties of the extracts used. The 
antimicrobial properties of the extracts used enhanced synergistically enhanced the 
antibiotic activity against Staphylococcus aureus, Escherichia coli and Enterococcus 
faecalis. One limitation in the green synthesis was to obtain a pure mono-dispersed 
sample of nano structures. Also, methods to quantify the amount of nanoparticles per 
ppm/ml need to be established to quantify the minimal dose of nanoparticle to bring 
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about the desired antimicrobial effect. The biogenic NP-drug composite could open new 
avenues for the development of drugs for multi-drug resistant bacteria. 
The fate of the nanoparticles in the cell is determined importantly based on its 
surface coatings. It was evident that bare nanoparticles elicit a different response 
compared to nanoparticles with different protein coatings of ALB and FBS. 
Nanoparticles with protein corona were less susceptible to cause cytotoxic effects in cells 
when compared to bare nanoparticles. Hence, protein coated nanoparticles could act as a 
good vector for drug therapy in cancer.  
Based on the investigations on the cytotoxicity and size of the nanoparticles the 
last part of this dissertation dealt with the development of sugar functionalized 
nanoparticles that can be developed for biodiagnostic use. Urinary tract infection (UTI) is 
a predominant condition in prostate cancer patients. Escherichia coli ORN178 (EC-178) 
is the uropathogen that causes recurrent infection by binding specifically to adhesins of 
prostate cancer cells (DU-145 cells). In this study, the binding time of EC-178 to DU-145 
cells, the cytotoxicity and uptake of plain and mannose functionalized and 20 and 200 nm 
GNPs (d-mannan (Mn)-GNPs) was investigated. It was seen that EC-178 binds and is 
inside the DU-145 cells by 3 h of incubation period. Plain 20 nm GNPs decrease the 
percentage of viable cells in 48 and 72 h in log and lag phase of DU-145 cells. It was also 
observed that the Mn-GNPs were taken up by the DU-145 cells significantly more than 
the plain GNPs.  
Also, gold nanoparticles of 200 nm size were functionalized with two distinct 
glycoconjugates mannose (Mn–Au NPs) and Neuαc(α2-3)-Gal-(β1-4)Glc–Paa (Sg–Au 
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NPs) in order to investigate primary and fine sugar specificity of uropathogenic E. 
coli ORN178 and enterotoxigenic E. coli 13762, respectively. Fine sugar specificity was 
obser ed when Neuαc(α2-3)-Gal-(β1-4)Glc–Paa functionalized Au NPs (Sg–Au NPs) 
specifically showed binding with E. coli 13762 but not with E. coli ORN178. This 
specificity of E. coli strains to identify and bind to characteristic sugar moieties can be 
used in the development of biodiagnostic tools with Au NPs as carriers for 
diagnosis/treatment of human and veterinary diseases. In regards to the growing 
antibiotic resistance of microorganisms, gold nanoparticles can also be functionalized 
specifically to reverse adhesion of E. coli to host tissue and can be detected by their 
optical properties. There is an ocean of information coming forth at a rapid rate; 
nanotechnology definitely gives scope to much more biomedical applications in cancer 
therapy.  
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